# Chapter 61: Psychological Factors Affecting Other Medical Conditions

## The Biological and Neurological Basis of Psychological Factors Affecting Other Medical Conditions

### Introduction

The conceptualization of health and illness has undergone a profound transformation, shifting from a purely biomedical model to a more integrated biopsychososcial framework (Dragoș & Tănăsescu, 2009; Scheid & Wright, 2017; Liu, 2011). This paradigm shift acknowledges that a patient's psychological state is not merely a reaction to physical illness but is an active and influential component in the etiology, exacerbation, and prognosis of a vast range of medical conditions (Levenson, 2008; Reid, 2018). The diagnostic category "Psychological Factors Affecting Other Medical Conditions" (PFAMC) formally captures this interplay, identifying instances where psychological or behavioral factors adversely influence a medical illness (Nash et al., 2014). These factors are diverse, encompassing established mental disorders such as major depression or anxiety, as well as psychological symptoms, personality traits, maladaptive coping styles, and stress-related physiological responses (Levenson, 2008; Nash et al., 2014).

From a biological standpoint, the influence of the psyche is not an abstract or metaphorical process; it is mediated through concrete, measurable neurobiological systems (Dragoș & Tănăsescu, 2009; Graham, 1967). Psychological states such as stress, depression, and anxiety translate into physiological changes through intricate networks involving the central nervous system (CNS), the endocrine system, and the immune system (Schneiderman et al., 2004; Anisman & Kusnecov, 2022; McEwen, 2020). Chronic or acute psychological stress, in particular, has been identified as a primary driver through which the mind exerts its influence on the body (Schneiderman et al., 2004; Anisman & Merali, 1999). Stressors, which can range from major traumatic events to chronic daily hassles, trigger a cascade of neuroendocrine and autonomic responses designed for adaptation and survival (Chu et al., 2019; Anisman & Merali, 1999). However, when these responses are prolonged, excessive, or dysregulated, they can contribute to the pathophysiology of numerous somatic diseases, including cardiovascular disease, metabolic disorders, and autoimmune conditions (Schneiderman et al., 2004; McEwen, 2020; Anisman et al., 2005).

The presence of a medical condition can, in turn, act as a significant stressor, creating a bidirectional and often vicious cycle where physical and mental health mutually deteriorate (Katz, 1999; Anisman & Hayley, 2012; Mercer et al., 2012). For example, a diagnosis of a chronic or life-threatening illness frequently precipitates psychological distress, including anxiety and depression, which then complicates the management of the primary medical condition and worsens its prognosis (Lloyd, 2007; Tancredi, 1983; Goodwin, 2006). This interplay underscores the necessity of viewing the patient holistically, recognizing that the mind and body are not separate entities but are in constant communication (Graham, 1967; Howells, 1982).

This chapter will provide a comprehensive overview of the biological and neurological mechanisms that underpin the impact of psychological factors on other medical conditions. We will explore the key neurobiological systems involved, including neurotransmitter pathways, the stress response axes, and neuro-immune interactions. Furthermore, we will examine the contributions of genetic and molecular factors, the structural and functional brain changes observed through neuroimaging, and the critical role of developmental periods in establishing long-term vulnerability. Finally, we will consider how this biological understanding informs treatment mechanisms and illuminates future directions for research and integrated clinical care. By elucidating these pathways, we move beyond a dualistic view of mind and body, toward a unified understanding of human health and disease.

### Neurobiological Systems

The translation of psychological states into physiological changes is orchestrated by a complex and interconnected network of neurobiological systems. These systems form the material basis for the mind-body connection, converting emotional and cognitive experiences into hormonal, neural, and immune signals that can profoundly affect somatic health. The primary systems implicated are the hypothalamic-pituitary-adrenal (HPA) axis, the autonomic nervous system (ANS), various neurotransmitter pathways, and the neuro-immune network.

#### The Hypothalamic-Pituitary-Adrenal (HPA) Axis and the Stress Response

The HPA axis is the body's central stress response system (Charmandari et al., 2003; Chu et al., 2019). When an individual perceives a situation as stressful, the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary gland to release adrenocorticotropic hormone (ACTH) (Stratakis et al., 1995). ACTH then travels to the adrenal cortex, stimulating the release of glucocorticoids, primarily cortisol in humans (McEwen, 2020). This cascade is adaptive in the short term, mobilizing energy and modulating immune responses to cope with an immediate threat (Chu et al., 2019; Selye, 1979).

However, chronic psychological stress—stemming from factors such as work-related pressures (Víu & Blasco, 2011), social isolation (Császár, 2014), or coping with a chronic illness (Tancredi, 1983)—can lead to dysregulation of the HPA axis (Claes, 2009; Anisman & Kusnecov, 2022). This dysregulation can manifest as hyperactivity, characterized by sustained excessive release of cortisol, or hypoactivity, a blunted response to stressors (Hellhammer & Wade, 1993; Sudheimer et al., 2013). Both patterns of dysregulation are associated with adverse health outcomes (McEwen, 2020). Prolonged exposure to high levels of cortisol can contribute to the pathophysiology of numerous medical conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome (Esch et al., 2002; Uribe Londoño et al., 2005; Shin et al., 2016). For example, HPA axis dysregulation is a proposed mechanism linking depression and stress to an increased risk of cardiovascular events (Giannoglou & Koskinas, 2014; Pignalberi et al., 2002; Oishe et al., 2025). The cumulative "wear and tear" on the body resulting from chronic over-activation or inefficient management of these physiological responses is termed "allostatic load" (McEwen, 2020). When allostatic load becomes excessive, it results in "allostatic overload," a state where coping resources are exceeded, predisposing the individual to illness (Fava et al., 2010; Porcelli et al., 2012).

Depression, a common psychological factor affecting medical conditions, is consistently associated with HPA axis abnormalities (Claes, 2009; Anisman et al., 2005). This neuroendocrine dysfunction may be a key biological pathway through which depression negatively impacts the course of somatic diseases like heart disease and cancer (Katz, 1999; Trill, 2012).

#### The Autonomic Nervous System

The Autonomic Nervous System (ANS) provides the rapid-response arm of the stress reaction, mediating the classic "fight or flight" response through its sympathetic branch (SAM axis) and promoting rest and recovery through its parasympathetic branch (Granger & Shelly, 1996; Chu et al., 2019). Psychological stressors, both acute and chronic, lead to activation of the sympathetic nervous system, resulting in the release of catecholamines—epinephrine and norepinephrine—from the adrenal medulla and sympathetic nerve endings (Schneiderman et al., 2004; Anisman & Merali, 1999).

This activation causes immediate physiological changes, such as increased heart rate, elevated blood pressure, and redistribution of blood flow to muscles (Hickam et al., 1948; Coca, 1994). While essential for survival in acute emergencies, chronic sympathetic hyperactivation is a major contributor to cardiovascular pathology (Giannoglou & Koskinas, 2014; Kop, 1999). It can promote hypertension, facilitate atherosclerosis, provoke vasoconstriction in diseased coronary arteries, and increase the risk of malignant arrhythmias and sudden cardiac death (Zikmund, 1997; Pignalberi et al., 2002; Giannoglou & Koskinas, 2014). Psychological factors like anger, hostility, and anxiety are strongly linked to heightened cardiovascular reactivity and are considered independent risk factors for coronary artery disease (Wolever, 2007; Császár, 2014; Allan & Scheidt, 1996). In patients with established heart disease, acute mental stress can directly trigger myocardial ischemia and other acute coronary syndromes (Graeber et al., 2007; Kop, 1999). The interaction of the ANS with other systems, such as platelets and inflammatory processes, further implicates it as a central mechanism through which psychological distress translates into cardiovascular morbidity and mortality (Kop, 1999; Pignalberi et al., 2002).

#### Neurotransmitter Systems and Neuropharmacology

Key neurotransmitter systems in the brain are integral to the regulation of mood, cognition, and behavior, and their dysregulation is a cornerstone of many psychiatric disorders that affect medical conditions (Shelton & Hunt, 2008). The monoamine systems—serotonin, dopamine, and norepinephrine—are particularly implicated.

*   **Serotonin (5-HT):** This system is crucial for mood regulation, anxiety, sleep, and appetite (Kennedy, 2008). Dysfunction in serotonergic pathways is a leading hypothesis for the neurobiology of depression and anxiety disorders (Goodwin, 2006; Nutt, 2001). The efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating depression and anxiety in medically ill patients underscores the role of this system (McCoy, 1996; Montejo et al., 2018). Furthermore, serotonin is involved in pain perception, and alterations in its function may contribute to the high comorbidity between chronic pain and depression (Dray, 1995; Maletic & DeMuri, 2016). Some research also suggests that serotonergic dysfunction may underlie impulsive behaviors that can negatively affect health, such as substance abuse or disordered eating (Pascual, 2003; Batinić et al., 2017).

*   **Dopamine (DA):** The dopaminergic system is central to the brain's reward, motivation, and pleasure circuits (Nestler & Carlezon, 2006). Anhedonia, the loss of interest or pleasure, is a core symptom of depression and is linked to hypoactivity in these pathways (Kennedy, 2008). This is particularly evident in the context of neurodegenerative disorders like Parkinson's disease, where degeneration of dopaminergic neurons causes motor symptoms but is also strongly associated with high rates of depression and apathy (Poewe & Luginger, 1999; Martínez‐Castrillo et al., 2011; Grachev, 2013). Pharmacological agents that modulate dopamine, such as certain antipsychotics and stimulants, can have profound effects on mood and motivation, highlighting the system's role in the interface between neurological and psychiatric symptoms (Stahl, 2002; Sarwer-Foner & Ogle, 1956).

*   **Norepinephrine (NE):** As a key neurotransmitter of the sympathetic nervous system, norepinephrine is involved in arousal, vigilance, and the stress response (Anisman & Merali, 1999). Dysregulation of the noradrenergic system, particularly in brain regions like the locus coeruleus, is implicated in both depression and anxiety disorders (Nutt, 2001). Antidepressants that target both serotonin and norepinephrine (SNRIs) are effective for a broad range of symptoms, including pain, which further supports the role of these monoamine systems in the complex presentations of medically ill patients (Maletic & DeMuri, 2016).

#### Neuro-immune Interactions

The immune system is not an autonomous entity but is in constant, bidirectional communication with the CNS (Anisman & Merali, 2003). Psychological stress and depression are potent modulators of immune function (Schneiderman et al., 2004; Kiecolt-Glaser & Glaser, 2001). Chronic stress and major depression are associated with a state of low-grade systemic inflammation, characterized by elevated levels of pro-inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) (Kiecolt-Glaser et al., 2015; Ravi et al., 2021; Hughes et al., 2016).

These cytokines can cross the blood-brain barrier or signal the brain via afferent nerves, influencing neurotransmitter metabolism, neuroendocrine function, and synaptic plasticity (Anisman et al., 2005; Anisman & Merali, 2003). This process can induce "sickness behaviors," including fatigue, anhedonia, social withdrawal, and cognitive disturbances, which overlap significantly with the symptoms of depression (Sharpe, 2010; Anisman et al., 2005). This neuro-immune pathway is thought to be a key mechanism by which psychological factors contribute to somatic illness (Ravi et al., 2021). For example, inflammation is a well-established driver of atherosclerosis and cardiovascular disease; thus, stress- and depression-induced inflammation may be a direct biological link between these psychological states and cardiac events (Teixeira et al., 2022; Császár, 2014). Similarly, immunotherapy with cytokines for cancer or hepatitis C can induce severe depressive symptoms, providing a clear clinical model of how inflammation can cause depression (Trill, 2012; Carroll & Rado, 2009). This bidirectional relationship, where stress promotes inflammation and inflammation contributes to depressive symptoms, creates a self-perpetuating cycle that can worsen both mental and physical health outcomes (Kiecolt-Glaser et al., 2015; Hughes et al., 2016).

### Genetic and Molecular Basis

The interplay between psychological factors and medical conditions is not uniform across all individuals. A significant portion of this variability can be attributed to genetic predispositions and underlying molecular mechanisms that confer vulnerability or resilience (Stahl, 2002; Claes, 2009). These factors influence the reactivity of neurobiological systems to stress and shape an individual's propensity to develop both psychiatric and somatic disorders.

#### Genetic Factors and Heritability

Vulnerability to the adverse effects of stress is, in part, heritable (Stahl, 2002). Family studies have long demonstrated that psychiatric conditions such as major depression and bipolar disorder have a significant genetic component (Cadoret & Winokur, 1972; Akiskal, 1983). This genetic loading may also predispose individuals to a more severe or prolonged psychological response when faced with a medical illness (Starkstein & Robinson, 1989; Bromberger & Woods, 2009). For instance, a family history of affective disorders is a known risk factor for developing post-stroke depression, suggesting that genetic vulnerability interacts with the neurological insult of the stroke (Robinson, 1997). Similarly, a genetic predisposition to anxiety may amplify the psychological distress associated with a cancer diagnosis or cardiac event (Császár, 2014; Trill, 2012).

Research has begun to identify specific gene polymorphisms that may mediate these effects. A prominent example is the polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR), which influences the reuptake of serotonin in the synapse (Claes, 2009). Individuals carrying the short allele of this gene may exhibit heightened amygdala reactivity to negative stimuli and are thought to be more susceptible to developing depression in response to stressful life events (Claes, 2009). Such genetic variations could explain why some individuals develop significant depressive symptoms in the context of a medical condition while others do not. Other genes implicated in stress system regulation, such as those related to CRH, glucocorticoid receptors, and brain-derived neurotrophic factor (BDNF), are also areas of active investigation (Claes, 2009; Pivac et al., 2010). Furthermore, genetic polymorphisms in drug-metabolizing enzymes, like the cytochrome P450 family (e.g., CYP2D6), can influence both an individual's response to psychotropic medications and potentially their baseline personality traits and vulnerability to psychopathology (Gram et al., 1993; Peñas‐Lledó et al., 2010).

#### Epigenetic Mechanisms

Epigenetics provides a crucial molecular link between environmental exposures, such as psychological stress, and long-term changes in gene expression that can predispose an individual to illness (McEwen, 2020; Anisman & Kusnecov, 2022). Epigenetic modifications, such as DNA methylation and histone acetylation, do not alter the DNA sequence itself but change how genes are read and expressed (Wolkowitz, 2018).

Early life stress, including childhood adversity or prenatal stress, is a potent driver of epigenetic changes (Ventriglio et al., 2015; van der Kolk, 1998). These experiences can lead to lasting modifications in genes that regulate the HPA axis, effectively "programming" an individual's stress response for life (Claes, 2009; Hoffmann & Heim, 2024). For example, stress-induced methylation can alter the expression of glucocorticoid receptors in the hippocampus, impairing the negative feedback loop of the HPA axis and leading to a state of chronic hypercortisolemia (Sudheimer et al., 2013). These epigenetic marks can persist into adulthood, creating a biological vulnerability that increases the risk of developing depression, anxiety, and related somatic conditions when faced with subsequent stressors (Holl & Barnow, 2017; Schwab & Rakers, 2022). This mechanism helps explain how psychological trauma can become biologically embedded, translating into physical disease decades later (van der Kolk, 1998; Anisman & Kusnecov, 2022). Epigenetic changes are also implicated in the process of "accelerated biological aging" observed in individuals with serious mental disorders, potentially linking psychological distress to premature somatic morbidity and mortality (Wolkowitz, 2018).

#### Molecular Pathways and Cellular Mechanisms

At the molecular level, several pathways have been identified that mediate the effects of psychological factors on cellular function. Brain-Derived Neurotrophic Factor (BDNF) is a key molecule involved in neuronal survival, growth, and synaptic plasticity (Pivac et al., 2010). Chronic stress and depression have been shown to decrease BDNF levels, particularly in the hippocampus and prefrontal cortex, which can lead to dendritic atrophy and neuronal loss in these regions (Duman et al., 2016). This reduction in neurotrophic support is thought to be a critical pathophysiological component of depression and its associated cognitive impairments (Szymkowicz et al., 2023). Pharmacological treatments, such as antidepressants, and non-pharmacological interventions, like exercise, may exert their therapeutic effects in part by increasing BDNF expression and promoting neurogenesis and synaptic plasticity (Collo & Pich, 2018; Smith & Blumenthal, 2015).

Inflammatory signaling pathways are another critical molecular link. As discussed, psychological stress activates the innate immune system, leading to the production of pro-inflammatory cytokines (Hughes et al., 2016; Anisman & Merali, 2003). These cytokines can trigger intracellular signaling cascades, such as the nuclear factor-kappa B (NF-κB) pathway, which further promotes inflammation (Ravi et al., 2021). This inflammatory state can contribute to insulin resistance, endothelial dysfunction, and other processes that underlie cardiometabolic diseases (Teixeira et al., 2022). Furthermore, inflammation can directly impact brain function by altering neurotransmitter synthesis (e.g., reducing serotonin) and promoting neurotoxic pathways, thereby contributing to the development of depressive symptoms (Kiecolt-Glaser et al., 2015; Anisman et al., 2005).

Oxidative stress, the imbalance between reactive oxygen species (ROS) and the body's antioxidant defenses, is another convergent pathway (Dhama et al., 2019). Both psychological stress and depression are associated with increased markers of oxidative stress (Wilson, 2014). Elevated ROS can damage lipids, proteins, and DNA, contributing to cellular aging and the pathogenesis of neurodegenerative and cardiovascular diseases (Shin et al., 2016). The interplay between inflammation and oxidative stress creates a damaging feedback loop, where each process can exacerbate the other, further linking psychological distress to cellular and tissue damage throughout the body (Kiecolt-Glaser et al., 2015).

### Brain Structure and Function

The brain is the central organ that interprets environmental stimuli, generates emotional and cognitive responses, and orchestrates the subsequent physiological reactions that affect the body (Levi, 1987; Schad, 2015). Persistent psychological distress, such as chronic stress, anxiety, and depression, is associated with demonstrable changes in the structure and function of key neural circuits. These alterations provide a neuroanatomical basis for how psychological factors can lead to maladaptive physiological states and increase the risk for medical diseases.

#### Key Brain Regions and Neural Circuits

A network of interconnected brain regions, often referred to as the cortico-limbic system, is centrally involved in emotion processing, stress regulation, and cognition. Dysfunction within this network is a hallmark of many psychiatric conditions that complicate medical illness (Mayberg & Lozano, 2002; Falkai et al., 2013).

*   **The Amygdala:** This almond-shaped structure in the medial temporal lobe is a critical hub for threat detection and the generation of fear and anxiety responses (Homberg & Contet, 2009; Shelton & Hunt, 2008). In anxiety disorders and following exposure to psychological trauma, the amygdala often becomes hyperactive, leading to a state of heightened arousal and vigilance (van der Kolk, 1998; Homberg & Contet, 2009). This hyperactivity can drive downstream activation of the HPA axis and sympathetic nervous system, contributing to the physiological manifestations of stress (Chu et al., 2019).

*   **The Hippocampus:** Located adjacent to the amygdala, the hippocampus is crucial for memory formation, particularly the contextual aspects of memory, and plays a key role in regulating the HPA axis (van der Kolk, 1998). It is rich in glucocorticoid receptors and is part of the negative feedback loop that terminates the cortisol response (Sudheimer et al., 2013). Chronic stress and elevated cortisol levels can be toxic to the hippocampus, leading to dendritic atrophy, reduced neurogenesis, and a decrease in overall volume (Adams et al., 2018; Worthen & Beurel, 2022). This structural change can impair memory and cognitive function, a common complaint in depression and chronic stress, and also disrupt HPA axis regulation, creating a vicious cycle of stress and neural damage (Post, 2018; van der Kolk, 1998).

*   **The Prefrontal Cortex (PFC):** The PFC, particularly the medial and orbitofrontal regions, is responsible for executive functions, including decision-making, impulse control, and the top-down regulation of emotion (Rowe, 2010; Fries, 2013). It exerts inhibitory control over the amygdala, helping to dampen fear and anxiety responses (Favre, 2014). In depression and anxiety disorders, the PFC often shows reduced activity and volume, which is thought to reflect impaired emotional regulation (Mayberg & Lozano, 2002; Adams et al., 2018). This hypofrontality can lead to a state of unchecked amygdala activity, contributing to persistent negative affective states (Favre, 2014).

*   **The Anterior Cingulate Cortex (ACC):** This region is a key integration hub for emotional, cognitive, and autonomic information (Derbyshire & Bremner, 2009). It is involved in error detection, conflict monitoring, and the perception of pain (Derbyshire & Bremner, 2009). Dysfunctional activity in the ACC is linked to both depression and chronic pain syndromes, providing a neural substrate for the high comorbidity between these conditions (Matisz & Gruber, 2020).

*   **The Basal Ganglia:** While primarily known for their role in motor control, structures within the basal ganglia, such as the striatum and nucleus accumbens, are also critical components of the brain's reward and motivation circuitry (Chatterjee & Marder, 2004). Dopaminergic pathways originating in the midbrain project to these areas. Dysfunction in this circuitry is implicated in the anhedonia and motivational deficits seen in depression, particularly in the context of Parkinson's disease, where degeneration of these pathways is the primary pathology (Martínez‐Castrillo et al., 2011; Poewe & Luginger, 1999).

#### Neuroimaging Findings

Advances in neuroimaging techniques, such as magnetic resonance imaging (MRI), functional MRI (fMRI), and positron emission tomography (PET), have allowed for the in-vivo visualization of these structural and functional brain changes.

*   **Structural Neuroimaging:** Structural MRI studies have consistently documented volumetric changes in the brains of individuals with chronic stress and depression. The most robust finding is a reduction in hippocampal volume, which is correlated with the duration of illness and exposure to early life trauma (Post, 2018; van der Kolk, 1998). Reductions in gray matter volume have also been reported in the PFC and ACC (Nasrallah, 2014; Favre, 2014). In the context of medical illness, neuroimaging can identify specific lesions that confer a high risk for psychiatric symptoms. For example, post-stroke depression is strongly associated with the location of the brain lesion, with left anterior frontal and left basal ganglia strokes carrying the highest risk (Starkstein & Robinson, 1989; Robinson, 1997). This "lesion method" provides compelling evidence for the neurological underpinnings of mood disorders (Robinson, 1997).

*   **Functional Neuroimaging:** Functional imaging studies have revealed patterns of abnormal neural activity and connectivity. In depression, a common finding is hyperactivity in the amygdala and subgenual ACC, coupled with hypoactivity in the dorsolateral PFC (Mayberg & Lozano, 2002; Favre, 2014). This pattern is thought to represent a state of heightened emotional reactivity with diminished cognitive control (Rowe, 2010). fMRI studies have also shown that psychological stressors can induce changes in brain activity that mirror those seen in physical pain, providing a neural basis for "psychogenic" or "functional" pain syndromes (Derbyshire & Bremner, 2009). Furthermore, successful treatment with either pharmacotherapy or psychotherapy can lead to the normalization of these abnormal patterns of brain activity, suggesting that these interventions work by modulating the function of these underlying neural circuits (Favre, 2014; Swann, 2014).

These structural and functional alterations in cortico-limbic circuits represent the final common pathway through which diverse genetic, developmental, and environmental factors converge to produce the psychological symptoms that can adversely affect medical conditions.

### Developmental Neurobiology

The brain is not a static organ; it undergoes a protracted period of development that extends from the prenatal period through adolescence and into early adulthood (Lockhart et al., 2018). During this time, there are critical and sensitive periods when the brain is particularly malleable and vulnerable to environmental influences, including psychological stress (Turk et al., 2007). Experiences during these developmental windows can have profound and lasting effects on neurobiological systems, establishing trajectories that influence mental and physical health throughout the lifespan (Scheid & Wright, 2017).

#### Early Life Stress and Critical Periods of Development

The impact of stress is heavily dependent on the developmental stage at which it occurs (Ventriglio et al., 2015). Early life, encompassing prenatal, infant, and childhood periods, is a time of rapid brain organization and plasticity (Carey, 1969). Adverse experiences during this time, such as maternal stress during pregnancy, neglect, or childhood abuse and trauma, can permanently alter the development of stress-response systems and brain circuits involved in emotion regulation (van der Kolk, 1998; Holl & Barnow, 2017; Verma & Agrawal, 2021).

Prenatal stress exposure is associated with long-term alterations in the offspring's HPA axis activity, often leading to a hyper-reactive stress response later in life (Schwab & Rakers, 2022; Charmandari et al., 2003). These effects are mediated by maternal stress hormones crossing the placenta and by epigenetic modifications to fetal genes that regulate the stress system (Schwab & Rakers, 2022). Similarly, postnatal adversity, such as insecure attachment or emotional maltreatment, disrupts the development of secure caregiver-child bonds, which are essential for learning self-regulation (Farina et al., 2019; Cooklin, 2013). This early trauma can lead to a state of chronic hyperarousal, emotional dysregulation, and a heightened vulnerability to a range of psychiatric disorders, including depression, anxiety, and post-traumatic stress disorder (PTSD) in adulthood (van der Kolk, 1998; Holl & Barnow, 2017). The biological embedding of this early trauma can manifest decades later as increased susceptibility to stress-related physical illnesses (Anisman & Kusnecov, 2022).

#### Adolescence: A Period of Vulnerability and Onset

Adolescence is another critical neurodevelopmental period, characterized by significant remodeling of neural circuits, particularly within the prefrontal cortex and its connections to limbic regions (Lockhart et al., 2018; McGorry & Yung, 2020). This period of synaptic pruning and myelination is essential for the maturation of executive functions and emotional control (Alberdi-Páramo & Pelaz-Antolín, 2019). However, this ongoing brain maturation also renders adolescents particularly vulnerable to the effects of stress and is a peak time for the onset of major mental illnesses, including mood disorders, anxiety disorders, and schizophrenia (Lockhart et al., 2018; McGorry & Yung, 2020; Paruk & Karim, 2016).

Stressors during adolescence, such as social rejection, academic pressure, or family conflict, can disrupt these normal developmental processes, potentially leading to long-term alterations in brain function and an increased risk for psychopathology (Lockhart et al., 2018). The onset of a psychiatric disorder during this formative period can have devastating consequences for psychosocial development, interfering with educational attainment, peer relationships, and the formation of a stable identity (McGorry & Yung, 2020). For example, the emergence of bipolar disorder in adolescence is often associated with a more severe and chronic course of illness compared to adult-onset cases (MacPherson, 2019; Swarupa Rani & Mehta, 2020).

The interaction between pre-existing neurodevelopmental vulnerabilities (whether genetic or resulting from early life stress) and the psychosocial challenges of adolescence creates a "perfect storm" for the emergence of psychological factors that can negatively impact medical health throughout life (Bramon & Murray, 2001). Understanding these developmental trajectories is crucial for designing effective early intervention and prevention strategies (McGorry & Yung, 2020; Constant & Belge, 2024).

### Treatment Mechanisms

Understanding the biological basis of how psychological factors affect medical conditions provides a rational framework for therapeutic interventions. Treatments, whether pharmacological or psychosocial, are increasingly understood to exert their effects by targeting and modulating the underlying neurobiological systems discussed in previous sections. The ultimate goal of these interventions is to restore homeostasis, promote neuroplasticity, and break the vicious cycles that link psychological distress with somatic pathology (Swann, 2014).

#### Neuropharmacological Interventions

Psychopharmacological agents are a cornerstone of treatment for many of the psychiatric disorders that complicate medical illness (Berger et al., 1977). These medications work by directly targeting the neurotransmitter systems involved in mood and anxiety regulation.

*   **Antidepressants:** Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are first-line treatments for depression and anxiety disorders (Kennedy, 2008; Baldwin & Brandish, 2014). By increasing the synaptic availability of serotonin and/or norepinephrine, these drugs help to normalize function in cortico-limbic circuits, reducing depressive symptoms and improving emotional regulation (Goodwin, 2006). Their use in medically ill patients can alleviate the psychological burden, which may in turn improve adherence to medical treatments and overall prognosis (McCoy, 1996; Montejo et al., 2018). Some antidepressants also have direct analgesic properties, making them particularly useful in patients with comorbid chronic pain (Maletic & DeMuri, 2016; Tütüncü, 2011).

*   **Antipsychotics:** Atypical (second-generation) antipsychotics, which modulate dopamine and serotonin receptor activity, are used to treat psychotic symptoms that can occur in severe depression, bipolar disorder, or delirium (Buckley, 2006; Lawlor, 2004). In lower doses, some of these agents are also used as augmenting agents in treatment-resistant depression, potentially by restoring balance in prefrontal dopaminergic pathways (Moukaddam & Shah, 2016). However, their use, especially in the elderly, must be carefully managed due to significant metabolic and cardiovascular side effects (Rayfield et al., 2014; Gaszner et al., 2017).

*   **Anxiolytics:** Benzodiazepines enhance the effect of the inhibitory neurotransmitter GABA, producing rapid anxiolytic and sedative effects (Senay, 1989). While effective for short-term management of acute anxiety or insomnia, their potential for dependence and cognitive side effects limits their long-term use, particularly in the elderly (Michel et al., 1993; Senay, 1989).

The choice of medication in a medically complex patient requires careful consideration of potential drug-drug interactions, side effect profiles, and the impact on the underlying medical condition (Greenblatt et al., 1976; Lamy, 1979). For example, some antidepressants can affect cardiac conduction, which is a critical consideration in patients with heart disease (Zięba et al., 1999).

#### Neuroplasticity, Compensatory Mechanisms, and Psychosocial Interventions

Pharmacological treatments do not act in a vacuum; they interact with the brain's inherent capacity for plasticity—the ability to reorganize its structure and function in response to experience (Swann, 2014). Psychosocial interventions, including various forms of psychotherapy, are powerful modulators of this process.

*   **Cognitive Behavioral Therapy (CBT):** CBT helps patients identify and modify maladaptive thought patterns and behaviors that contribute to depression and anxiety (Bothwell, 2003). From a neurobiological perspective, CBT is thought to work by strengthening top-down cognitive control from the prefrontal cortex over a hyperactive amygdala (Favre, 2014). By teaching new coping skills, CBT can reduce the physiological stress response to challenging situations, thereby lessening the allostatic load on the body (Schneiderman et al., 2004).

*   **Psychoeducation and Self-Management:** Educating patients about the bidirectional link between their psychological state and their physical health is a crucial intervention (Colom et al., 2006). This approach empowers patients, enhances their sense of control, and improves adherence to both medical and psychiatric treatments (Carvajal, 2004; Sonino & Fava, 2007). Interventions that promote healthy lifestyle changes—such as regular exercise, a balanced diet, and adequate sleep—can have profound effects on mental and physical health by reducing inflammation, increasing BDNF, and regulating the HPA axis (Sarris et al., 2014; Smith & Blumenthal, 2015).

*   **Stress Management and Relaxation Techniques:** Interventions like mindfulness-based stress reduction (MBSR), meditation, and biofeedback directly target the physiological stress response (Esch et al., 2013). These techniques can reduce sympathetic nervous system activity, lower cortisol levels, and decrease inflammation, thereby mitigating the harmful biological effects of stress (Canella et al., 2025; Oken, 2000).

The most effective treatment approaches often integrate pharmacological and psychosocial strategies (Swann, 2014; Thase et al., 2014). Medication can provide the initial symptom relief necessary for a patient to engage effectively in psychotherapy (Sporty & Plon, 1984), while therapy can provide the long-term skills needed to manage stress and prevent relapse, ultimately promoting lasting neurobiological changes and resilience (Fava & Visani, 2008).

### Future Directions

While our understanding of the neurobiological links between psychological factors and medical conditions has advanced significantly, the field remains replete with unanswered questions and opportunities for future research. The current body of evidence is largely based on associations, and a primary goal for future work is to more clearly delineate causal pathways and the directionality of these complex relationships (Anisman & Hayley, 2012).

A critical need exists for more longitudinal, prospective studies that can track individuals over time, ideally from before the onset of illness. Such studies would help to disentangle whether certain biological markers (e.g., inflammation, HPA axis dysregulation) are precursors to both psychological and physical illness, or whether they are consequences of one or the other (Guiraud & Touzé, 2013). This research is essential for moving from risk association to true prevention (Constant & Belge, 2024).

The identification and validation of robust biomarkers remains a key priority (Anisman & Hayley, 2012). While markers like pro-inflammatory cytokines, cortisol levels, and neuroimaging findings are promising, they currently lack the specificity required for routine clinical diagnosis or for guiding individual treatment decisions (Breitenstein et al., 2014). Future research should aim to identify panels of biomarkers—combining genetic, epigenetic, neuroendocrine, immune, and neuroimaging data—that can define distinct biological subtypes or "biotypes" of disorders. This would facilitate a move toward precision psychiatry, where treatments are tailored to the specific underlying pathophysiology of an individual patient, rather than a broad syndromal diagnosis (Sampogna et al., 2023; Alda, 2017).

The development of novel therapeutic targets is another exciting frontier. As our understanding of molecular pathways deepens, new opportunities for pharmacological intervention will emerge (Ventriglio et al., 2015). For example, agents that target inflammatory pathways, modulate glutamatergic systems (as with ketamine), or promote neuroplasticity and resilience are currently under intense investigation (Collo & Pich, 2018; Hughes et al., 2016). Similarly, non-invasive brain stimulation techniques, such as transcranial magnetic stimulation (TMS), offer a way to directly modulate activity in the dysfunctional neural circuits identified through neuroimaging, providing a targeted, non-pharmacological approach to treatment (Rothärmel et al., 2017).

Furthermore, the integration of technology into mental health care holds significant promise. Digital platforms and wearable sensors can provide real-time, objective monitoring of physiological and behavioral indicators of stress and mood, allowing for earlier detection of problems and more timely interventions (Kanbara & Morita, 2020). These technologies can also deliver scalable psychosocial interventions, increasing access to care for populations that are often underserved (Thompson & Ski, 2013).

Finally, a greater emphasis on the full spectrum of recovery is needed. Clinical trials and practice must move beyond a narrow focus on symptom reduction to include measures of functional recovery, psychological well-being, and quality of life (Fava & Visani, 2008; Keller, 2004). True recovery involves not just the absence of symptoms, but a restoration of social and occupational functioning and a renewed sense of purpose and vitality (Fava & Visani, 2008). Research into "positive psychiatry," which focuses on building resilience and promoting well-being, may yield interventions that not only treat illness but also foster lasting health (Verdolini & Vieta, 2021). Answering these questions will require a multidisciplinary, collaborative approach, breaking down the traditional silos between psychiatry, neurology, immunology, endocrinology, and other medical specialties.

### Conclusion

The evidence overwhelmingly demonstrates that psychological factors are potent modulators of physical health, exerting their influence through a complex and interconnected web of neurobiological systems. The traditional Cartesian dualism that separated mind and body has become untenable in the face of modern scientific inquiry (Graham, 1967). Psychological phenomena such as stress, depression, and anxiety are not abstract experiences but are embodied processes with tangible consequences for the nervous, endocrine, and immune systems (Schneiderman et al., 2004; Anisman & Kusnecov, 2022). Chronic activation of stress pathways, dysregulation of key neurotransmitters, and a persistent pro-inflammatory state represent the core biological mechanisms through which the mind affects the body, contributing to the onset and progression of a wide array of medical conditions, most notably cardiovascular disease (Giannoglou & Koskinas, 2014; Kop, 1999).

Our understanding of these mechanisms is rooted in a developmental context, where early life experiences can biologically embed vulnerability through epigenetic programming, shaping an individual's lifelong reactivity to stress (Ventriglio et al., 2015; van der Kolk, 1998). This vulnerability interacts with genetic predispositions and subsequent life stressors, culminating in the structural and functional brain changes observed in depression and anxiety disorders—changes centered on a dysregulated cortico-limbic network (Favre, 2014; Post, 2018).

This neurobiological framework provides a clear rationale for an integrated, biopsychosocial approach to patient care (Scheid & Wright, 2017). It validates the importance of addressing the psychological and social dimensions of illness, not as ancillary concerns, but as central components of comprehensive medical management (Turk, 1996). Both psychopharmacological and psychotherapeutic interventions derive their efficacy from their ability to modulate these underlying biological pathways, whether by correcting neurotransmitter imbalances or by promoting neuroplasticity and strengthening regulatory brain circuits (Swann, 2014).

Ultimately, the study of psychological factors affecting other medical conditions is the study of the human organism as an integrated whole. By continuing to unravel the intricate biological dialogue between the brain and the body, we can move toward a more sophisticated and effective model of medicine—one that not only treats disease but also promotes resilience, well-being, and a more complete vision of health.



## References

1. Abdo, C. H. N. (2017). Sexualidade e doenças reumáticas. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2017.16.3.6-12
2. Abe, Y., & Germai, A. (2012). Insomnia and Its Correlates: Current Concepts, Epidemiology, Pathophysiology and Future Remarks. InTech eBooks. https://doi.org/10.5772/36102
3. Abhishek, A., & Doherty, M. (2016). Placebo, nocebo, and contextual effects. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199668847.003.0027
4. Adams, T. G., Kelmendi, B., Brake, C. A., Gruner, P., Badour, C. L., & Pittenger, C. (2018). The Role of Stress in the Pathogenesis and Maintenance of Obsessive-Compulsive Disorder. Chronic Stress. https://doi.org/10.1177/2470547018758043
5. Agudelo, D., Spielberger, C. D., & Buela‐Casal, G. (2007). La depresión: ¿un trastorno dimensional o categorial?. Salud Mental.
6. Akiskal, H. S. (1983). The Relationship of Personality to Affective Disorders. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1983.01790060099013
7. Alanbagi, A. A., & Al-Zamily, R. H. (2019). The depression among cancer patients during chemotherapy and its relation to demographic and social data. International Journal of Research in Pharmaceutical Sciences.
8. Alao, A., Malhotra, K., Pies, R. W., & Dewan, M. (2004). Pharmacological strategies in treatment-resistant depression. West African Journal of Medicine. https://doi.org/10.4314/wajm.v22i3.27952
9. Alberdi-Páramo, Í., & Pelaz-Antolín, A. (2019). Emocionalidad y temperamento en el trastorno por déficit de atención con o sin hiperactividad. Revista de Neurología. https://doi.org/10.33588/rn.6908.2019032
10. Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
11. Alda, M. (2017). Who are excellent lithium responders and why do they matter?. World Psychiatry. https://doi.org/10.1002/wps.20462
12. Alexander, J. L., Dennerstein, L., Woods, N. F., McEwen, B. S., Halbreich, U., Kotz, K., & Richardson, G. (2007). Role of stressful life events and menopausal stage in wellbeing and health. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.7.11s.s93
13. Alexopoulos, G. S. (1995). Methodology of Treatment Studies in Geriatric Depression. American Journal of Geriatric Psychiatry. https://doi.org/10.1097/00019442-199503040-00002
14. Ali, A. M., Al‐Dossary, S. A., Laranjeira, C., Atout, M., Khatatbeh, H., Selim, A., Alkhamees, A. A., Aljaberi, M. A., Pakai, A., & Al‐Dwaikat, T. (2024). Cardiometabolic Morbidity (Obesity and Hypertension) in PTSD: A Preliminary Investigation of the Validity of Two Structures of the Impact of Event Scale-Revised. Journal of Clinical Medicine. https://doi.org/10.3390/jcm13206045
15. Aliieva, T. (2014). Features of Social Dysfunction In Students with Congenital Heart Disease, And Principles of Psychocorrection.
16. Allende-Rayme, F. R., Acuña-Vila, J. H., Quezada, J. C. R., & Correa-López, L. E. (2021). Lifestyle Medicine and Sleep Quality in Medical Students. Revista de la Facultad de Medicina Humana. https://doi.org/10.25176/rfmh.v21i2.3716
17. Amaral, A. K. B., Nobre, E. A. Q., & Barbosa, F. K. (2015). PARALISIA CEREBRAL: SEUS PARADIGMAS, AVANÇOS E RETROCESSOS. UNILUS Ensino e Pesquisa.
18. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
19. Anandhi, M. (2020). Health Humanities: Dealing with Depression and the Power of Books to help sustain the Journey- Reviews &amp; Inferences. Shanlax International Journal of English. https://doi.org/10.34293/english.v9is1-i2-dec.3693
20. Anghel, L., Boev, M., Stănescu, C., Caramfil, S. M., Luca, L., Mușat, C. L., & Ciubară, A. (2023). Depression in the Diabetic Patient. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/14.4/526
21. Anisman, H., & Hayley, S. (2012). Illness comorbidity as a biomarker?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.120092
22. Anisman, H., & Kusnecov, A. W. (2022). Stressors: Psychological and neurobiological processes. Cancer. https://doi.org/10.1016/b978-0-323-91904-3.00005-7
23. Anisman, H., & Merali, Z. (1999). Understanding stress: characteristics and caveats.. PubMed.
24. Anisman, H., & Merali, Z. (2003). Cytokines, stress and depressive illness: brain‐immune interactions. Annals of Medicine. https://doi.org/10.1080/07853890310004075
25. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies. Current Pharmaceutical Design. https://doi.org/10.2174/1381612053381701
26. Antoniuk, S. A. (2013). [Non-epileptic disorders in infancy and adolescence].. PubMed.
27. Apóstolo, J., Cooke, R., Bobrowicz‐Campos, E., Santana, S., Marcucci, M., Cano, A., Vollenbroek-Hutten, M., & Holland, C. (2016). Effectiveness of the interventions in preventing the progression of pre-frailty and frailty in older adults: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2016-2467
28. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
29. Araújo, R. C. B., Gomes, R. M., & Barbosa, M. U. F. (2017). A IMPORTÂNCIA DO BOBATH EM PACIENTES COM PARALISIA CEREBRAL.
30. Aretouli, E., Malik, M., Widmann, C., Parker, A. M., Oh, E. S., & Vannorsdall, T. D. (2025). Cognitive and mental health outcomes in long covid. BMJ. https://doi.org/10.1136/bmj-2024-081349
31. Arroyo, H., Klipstein, K., Ernst, C. L., & Finkel, J. H. (2016). Somatic Symptom and Related Disorders, Including Illness Anxiety, Factitious, Malingering, and Conversion Disorders. https://doi.org/10.1002/9781118654231.ch20
32. As, T. (2013). [Age-related aspects of depressive states].. PubMed.
33. Asad, F., Jahangarad, S., & Dorgalaleh, A. (2023). Psychological complications among patients with congenital bleeding disorders. Blood Coagulation & Fibrinolysis. https://doi.org/10.1097/mbc.0000000000001191
34. Asadolahi, F. (2013). 715 – Medication and psychosomatic. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)75937-6
35. Atler, K., & Michel, G. S. (1996). Maximizing abilities: occupational therapy's role in geriatric psychiatry. Psychiatric Services. https://doi.org/10.1176/ps.47.9.933
36. Auffret, M., Meuric, V., Boyer, É., Bonnaure‐Mallet, M., & Vérin, M. (2021). Oral Health Disorders in Parkinson’s Disease: More than Meets the Eye. Journal of Parkinson s Disease. https://doi.org/10.3233/jpd-212605
37. Austin, K. W., Ameringer, S., Starkweather, A., Cloud, L., Sturgill, J., & Elswick, R. K. (2016). Biobehavioral Framework of Symptom and Health Outcomes of Uncertainty and Psychological Stress in Parkinson Disease. Journal of Neuroscience Nursing. https://doi.org/10.1097/jnn.0000000000000244
38. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
39. Avari, J., Yuen, G. S., AbdelMalak, B., Mahgoub, N., Kalayam, B., & Alexopoulos, G. S. (2014). Assessment and Management of Late-Life Depression. Psychiatric Annals. https://doi.org/10.3928/00485713-20140306-04
40. Aviram, R. B., Brodsky, B. S., & Stanley, B. (2006). Borderline Personality Disorder, Stigma, and Treatment Implications. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220600975121
41. Awan, K., & Steinberg, M. H. (2017). Medical Conditions That May Cause Cognitive Impairment and Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199959549.003.0005
42. Aydinak, S., Yalçın, C. Ö., & Abudayyak, M. (2018). Psychiatric Adverse Effects of Non-steroidal Analgesic Anti-inflammatory Drugs. Journal of Literature Pharmacy Sciences. https://doi.org/10.5336/pharmsci.2017-58076
43. Aziz, S., Shahriar, S., & Arifuzzaman, M. (2022). A case report of somatic symptom disorder with suicidal tendencies. Bangladesh Journal of Psychiatry. https://doi.org/10.3329/bjpsy.v36i1.72241
44. Ba, V. D. K. (1998). [Psychology and psychobiology of childhood trauma].. PubMed.
45. Bahall, M. (2020). Depression: A Major Psychosocial-Lifestyle Sequela of Cardiac Disease Diagnosis. Journal of Health and Medical Sciences. https://doi.org/10.31014/aior.1994.03.03.133
46. Baldwin, D. S., & Brandish, E. K. (2014). Pharmacological Treatment of Anxiety Disorders. https://doi.org/10.1002/9781118775349.ch43
47. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
48. Balladares, L., & Rocío, M. D. (2018). Programa educativo Para disminuir la incidencia de los trastornos psicológicos que afectan el estado de salud a las madres adolescentes de 12 a 17 años de edad y sus cuidados hacia el recién nacido en el hospital general Puyo.
49. Bansal, J., Bansal, A., Shahi, M. K., Kedige, S., & Narula, R. (2014). Periodontal Emotional Stress Syndrome: Review of Basic Concepts, Mechanism and Management. Open Journal of Medical Psychology. https://doi.org/10.4236/ojmp.2014.33026
50. Barker, R. A., & Redfern, C. (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
51. Barkin, R. L. (2007). Zolpidem Extended-Release: A Single Insomnia Treatment Option for Sleep Induction and Sleep Maintenance Symptoms. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0b013e31804c7292
52. Barnes, E., & Bruera, É. (2002). Fatigue in patients with advanced cancer: A review. International Journal of Gynecological Cancer. https://doi.org/10.1046/j.1525-1438.2002.t01-1-01147.x
53. Barnes, T. R. E., & Paton, C. (2011). Do antidepressants improve negative symptoms in schizophrenia?. BMJ. https://doi.org/10.1136/bmj.d3371
54. Barnett, S., & Riddle, M. A. (2005). Conduct Disorder. CRC Press eBooks. https://doi.org/10.1201/b14120-78
55. Baron, D., Hay, D. P., & Easom, H. M. (2003). Treating patients in primary care: the impact of mood, behavior, and thought disturbances.. PubMed.
56. Barrio, A. G. D. (2018). Intervención Psicoterapéutica Integrada y Transdiagnóstica en los Trastornos de la Conducta Alimentaria. Revista de Psicoterapia. https://doi.org/10.33898/rdp.v29i110.248
57. Barrio, P., & Maria, A. D. (2017). La patología psiquiátrica en la incapacidad permanente.
58. Barsky, A. J. (1983). Nonpharmacologic Aspects of Medication. Archives of Internal Medicine. https://doi.org/10.1001/archinte.1983.00350080050013
59. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
60. Baskin, S. M. (2008). Psychiatric Comorbidity and Causes of Headache. https://doi.org/10.1093/oso/9780195366730.003.0010
61. Bassil, N., Ghandour, A., & Grossberg, G. T. (2011). How Anxiety Presents Differently in Older Adults: Age-Related Changes, Medical Comorbidities Alter Presentation and Treatment. Current psychiatry.
62. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
63. Bauer, M. S. (2008). Mood Disorders: Bipolar (Manic–Depressive) Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch67
64. Beaudreau, S. A., & Gould, C. E. (2015). Definition of Mental Disorder. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa190
65. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
66. Belardinelli, C., & Raza, M. (2016). Comorbid Behavioral Problems and Psychiatric Disorders in Autism Spectrum Disorders. Journal of Childhood & Developmental Disorders. https://doi.org/10.4172/2472-1786.100011
67. Belge, J.-B., & Constant, E. (2024). [Prevention of psychiatric illness].. PubMed.
68. Belleville, G., & Morin, C. M. (2003). Approches cognitivo-comportementales dans la gestion de l'insomnie secondaire à la douleur chronique. Douleur et Analgésie. https://doi.org/10.1007/bf03007112
69. Benbow, S., & Jagus, C. E. (2002). Sexuality in older women with mental health problems. Sexual & Relationship Therapy. https://doi.org/10.1080/14681990220149068
70. Bender, C. M., & Merriman, J. D. (2014). Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?. PubMed.
71. Benedetti, F. D. (2008). A modern view of placebo and placebo-related effects. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199559121.003.0002
72. Berg, A. T. (2011). Epilepsy, cognition, and behavior: The clinical picture. Epilepsia. https://doi.org/10.1111/j.1528-1167.2010.02905.x
73. Berger, P. A., Hamburg, B. A., & Hamburg, D. A. (1977). Mental health: progress and problems.. PubMed.
74. Berk, M., Post, R. M., Ratheesh, A., Gliddon, E., Singh, A., Vieta, E., Carvalho, A. F., Ashton, M. M., Berk, L., Cotton, S., McGorry, P. D., Fernandes, B. S., Yatham, L. N., & Dodd, S. (2017). Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. https://doi.org/10.1002/wps.20441
75. Berkowsky, R. W. (2014). Aging and Stress. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. https://doi.org/10.1002/9781118410868.wbehibs020
76. Bernardo, A. P. M. (2003). O delírio em cuidados paliativos. Revista Portuguesa de Medicina Geral e Familiar. https://doi.org/10.32385/rpmgf.v19i1.9904
77. Bertschy, G. (2007). La dépression dans les maladies fatales. InfoKara. https://doi.org/10.3917/inka.071.0013
78. Bhardwaj, S., Kaur, R., Kumari, P., Sharma, S. K., Pasricha, C., Jamwal, N., Singh, R., Arora, P., Kaur, P., & Sahu, S. K. (2024). A Scoping Review and Preliminary Illustrative Analysis of Biomarkers in Stress-Related Psychiatric Illness: Diagnostic and Prognostic Implications. BIO Web of Conferences. https://doi.org/10.1051/bioconf/20248601039
79. Bhingardive, S. S., & Salve, P. (2022). Assessment of Knowledge Regarding Postpartum Psychiatric Disorders Among the Relatives of Primigravida in Selected Hospitals of the City. Acta Scientific Women s Health. https://doi.org/10.31080/aswh.2022.04.0340
80. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
81. Bivoleanu, A., Avasiloaiei, A., Moscalu, M., & Stamatin, M. (2017). The Role of Follow-up in Monitoring the Outcomes of Prematurity in a Cohort of Romanian Infants. Balkan Medical Journal. https://doi.org/10.4274/balkanmedj.2015.1125
82. Bjørk, M., & Eberhard‐Gran, M. (2018). Perinatal Depression in Neurological Disease and Disability. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190667351.003.0034
83. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
84. Blumenfeld, R. S. (2020). Neuropsychiatric Disorders. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch288
85. Blumenfeld, R. S. (2020). Neuropsychiatric Disorders. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781119547181.ch288
86. Bobo, W. V., Altamura, A. C., & Meltzer, H. Y. (2007). Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e3280de2c7f
87. Boer, M., Udangiu, N., & Ţilea, L. (2014). THEORETICAL APPROACH ABOUT THE ADAPTIVE RESPONSES IN DISASTER PSYCHIATRY. Management in Health. https://doi.org/10.5233/mih.v18i1.304
88. Bogado, C. E. (2006). Bone Quality. CRC Press eBooks. https://doi.org/10.1201/b14631-12
89. Bogduk, N. (2006). Commentary Psychology and low back pain.
90. Bothwell, R. (2003). Cognitive behaviour therapy for psychosomatic disorders : main topic. CME: Your SA Journal of CPD.
91. Bottesi, G. (2013). Pathological Gambling: Compulsive-Impulsive Spectrum Disorder, Behavioural Addiction, or Both?.
92. Bourvis, N., Aouidad, A., Cabelguen, C., Cohen, D., & Xavier, J. (2017). How Do Stress Exposure and Stress Regulation Relate to Borderline Personality Disorder?. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2017.02054
93. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
94. Bošković-Đukić, D. (2009). Family role in pathological gambling prevention. Zdravstvena zastita. https://doi.org/10.5937/zz0904031b
95. Bradic, L., Lokmić-Pekić, I., & Dzevad, B. (2018). Psychiatric comorbidity in patients with posttraumatic stress disorder and enduring personality change after catastrophic experience. https://doi.org/10.26226/morressier.5b68175cb56e9b005965c22b
96. Brahem, M. B. (2016). Conception, réalisation et étude d'un dispositif d'évaluation des risques de déséquilibre lors de la marche.
97. Bramon, E., & Murray, R. (2001). A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2001.3.4/ebramon
98. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
99. Brewer, B. W. (2017). Psychological Responses to Sport Injury. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.172
100. Bromberger, J. T., & Woods, N. F. (2009). Nonhormonal Factors Associated with Psychiatric Morbidity during the Menopausal Transition and Midlife. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000209601
101. Bruce, M. A., Thorpe, R. J., Schneider, R. H., Hercz, A. E., Williams, S. F., & Norris, K. C. (2025). Contemplative Practices as a Form of Stress Management for Patients with Kidney Disease. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000000829
102. Brufau, R. M., Serrano, R. S., & Caus, T. O. (2014). Regulación emocional, trastorno límite de la personalidad y juego patológico: a propósito de un caso..
103. Brunner, S. (2016). What impact does the pharmaceutical industry have on the medical definition of depression.
104. Bryant, R. A. (2022). Post‐traumatic stress disorder as moderator of other mental health conditions. World Psychiatry. https://doi.org/10.1002/wps.20975
105. Buckley, P. (2006). Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.. PubMed.
106. Budiman, M. W. (2002). MODULASI RESPONS IMUN PADA MENCIT BALB/c YANG STRES AKIBAT STRESOR SUARA.
107. Bukhari, S. N. A. (2022). Consequences of Antipsychotic Medications on Mental Health. Current Drug Safety. https://doi.org/10.2174/1574886317666220216101106
108. Buljan, D. (2009). Psychological and psychiatric factors of chronic pain.
109. Burton, K., & Kendall, N. (2014). ABC of Occupational and Environmental Medicine, 3rd EditionMusculoskeletal Disorders.
110. Butler, A., & Pritchard, C. (1983). Psychiatric Emergencies. https://doi.org/10.1007/978-1-349-17192-7_9
111. Cabaniss, D. L., Moga, D. E., & Hyun, A. (2013). The psychodynamic treatment of mood disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.022
112. Cabrera, D., & Teresa, M. (2019). Intervención cognitiva conductual y dialéctica conductual en la conducta suicida.
113. Cabrera, U., & Ángela, M. (2016). Trastorno de somatización y su incidencia en el desarrollo afectivo de los jóvenes de la ciudadela la Judith del cantón Quevedo..
114. Cadoret, R. J., & Winokur, G. (1972). Genetic Principles in the Classification of Affective Illnesses. International Journal of Mental Health. https://doi.org/10.1080/00207411.1972.11448572
115. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Post-Stroke Apathy: An Exploratory Longitudinal Study. Cerebrovascular Diseases. https://doi.org/10.1159/000350202
116. Caeiro, L., Ferro, J. M., Melo, T. P. E., Canhão, P., & Figueira, M. L. (2013). Supplementary Material for: Post-Stroke Apathy: An Exploratory Longitudinal Study. Figshare. https://doi.org/10.6084/m9.figshare.5124829
117. Callahan, C. M., Austrom, M. G., & Unverzagt, F. W. (2004). Dementia and Late-Life Depression. https://doi.org/10.1093/oso/9780195149395.003.0021
118. Canella, R., Fazia, T., & Gardi, C. (2025). Mindfulness-based stress reduction program improves psychological well-being and blood pressure in an Italian context: potential mechanisms and benefits. Psychology Health & Medicine. https://doi.org/10.1080/13548506.2025.2561740
119. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
120. Carbonella, S., Coniglio, M., Mistura, E. L., & Righi, O. (2023). Figli, genitori e curanti nella malattia: ruolo della genitorialità nella relazione terapeutica. PNEI REVIEW. https://doi.org/10.3280/pnei2023-002004
121. Carey, W. B. (1969). Psychologic Sequelae of Early, Infancy Health Crises. Clinical Pediatrics. https://doi.org/10.1177/000992286900800809
122. Carota, A., & Bogousslavsky, J. (2017). Catastrophe Reaction and Emotionalism. Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences. https://doi.org/10.1159/000475695
123. Carroll, V. K., & Rado, J. (2009). Is a Medical Illness Causing Your Patient's Depression? Endocrine, Neurologic, Infectious, or Malignant Processes Could Cause Mood Symptoms. Current psychiatry.
124. Caruso, G. M., & Kertay, L. (2019). Part I: Psychological Factors in Delayed and Failed Recovery and Unnecessary Disability. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2019.mayjun01
125. Carvajal, C. (2004). Poor response to treatment: beyond medication. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2004.6.1/ccarvajal
126. Carvajal, C. (2004). Poor response to treatment: beyond medication.. PubMed.
127. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
128. Casey, M., Perera, D. N., & Clarke, D. M. (2012). Psychosocial treatment approaches to difficult-to-treat depression. The Medical Journal of Australia. https://doi.org/10.5694/mjao12.10629
129. Castillo, G., & Dolores, M. (2016). Características de personalidad, psicopatológicas y de interacción familiar relacionadas con los trastornos del comportamiento alimentario. TDR (Tesis Doctorales en Red).
130. Chaouloff, F., Dubreucq, S., Matias, I., & Marsicano, G. (2013). Physical activity feel-good effect:The role of endocannabinoids. Routledge eBooks. https://doi.org/10.4324/9780203132678-12
131. Charlton, S. R. (2020). Psychology and Black History Month in the United States. Eye on Psi Chi Magazine. https://doi.org/10.24839/2164-9812.eye24.4.18
132. Charmandari, E., Kino, T., Souvatzoglou, E., & Chrousos, G. P. (2003). Pediatric Stress: Hormonal Mediators and Human Development. Hormone Research in Paediatrics. https://doi.org/10.1159/000069325
133. Chatterjee, A., & Marder, K. (2004). Basal Ganglia Disease And Depression. https://doi.org/10.1093/oso/9780195152746.003.0028
134. Chavan, B., & Das, S. (2015). Is psychiatry intervention in Indian setting complete?. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.171859
135. Chew, B. (2014). Psychological aspects of diabetes care: Effecting behavioral change in patients. World Journal of Diabetes. https://doi.org/10.4239/wjd.v5.i6.796
136. Choi‐Kwon, S., & Kim, J. S. (2022). Anger, a Result and Cause of Stroke: A Narrative Review. Journal of Stroke. https://doi.org/10.5853/jos.2022.02516
137. Christiansen, S. L., Bouzinova, E. V., & Breznoščáková, D. (2017). Depression. InTech eBooks. https://doi.org/10.5772/63698
138. Chu, B., Marwaha, K., Sanvictores, T., & Ayers, D. (2019). Physiology, Stress Reaction. StatPearls.
139. Chumpitazi, C. E. (2018). Moderate Adverse Events. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190659110.003.0023
140. Ciołkiewicz, M., Kuryliszyn-Moskal, A., Hryniewicz, A., & Kamiński, K. (2019). Sarcopenia and myokines profile as risk factors in cardiovascular diseases?. Postępy Higieny i Medycyny Doświadczalnej. https://doi.org/10.5604/01.3001.0013.5442
141. Claes, S. (2009). [Stress and depression: clinical, neurobiological and genetical perspectives].. PubMed.
142. Clare, F., Kristie, S., & Brown, K. (2020). Predictors of Health-Related Quality of Life and Communicative Participation in Individuals with Dysarthria from Parkinson's Disease. International Journal of Neurodegenerative Disorders. https://doi.org/10.23937/2643-4539/1710014
143. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. II. Stress and distress.. PubMed.
144. Clark, J. D., Rager, D. R., & Calpin, J. P. (1997). Animal well-being. III. An overview of assessment.. PubMed.
145. Clarke, S., Murphy, B., Hester, R., & Jackson, A. C. (2022). How does illness uncertainty impact recovery among patients with cardiac conditions?. British Journal of Cardiac Nursing. https://doi.org/10.12968/bjca.2022.0102
146. Coca, A. (1994). Circadian rhythm and blood pressure control: physiological and pathophysiological factors.. PubMed.
147. Coimbra, I. B. (2017). Avaliação dos fatores psicossociais, estratégias de "coping" e síndrome de "Burnout" na residência médica. https://doi.org/10.47749/t/unicamp.2017.988423
148. Collo, G., & Pich, E. M. (2018). Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression. Neural Regeneration Research. https://doi.org/10.4103/1673-5374.230288
149. Colom, F., Vieta, E., & Scott, J. (2006). Psychological treatment and bipolar disorders: why psychoeducate?. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543685.007
150. Colón‐Emeric, C., Whitson, H. E., Pavon, J. M., & Hoenig, H. (2013). Functional decline in older adults.. PubMed.
151. Conners, C. K. (2003). CORE SYMPTOMS VS FUNCTIONAL OUTCOMES IN ADHD: ARE THEY DIFFERENT THERAPEUTIC TARGETS? *.
152. Contreras, V., & Sobeida, M. (2019). Factores estresantes y fobia social en una adolescente.
153. Cooklin, A. (2013). Promoting children's resilience to parental mental illness: engaging the child's thinking. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.bp.111.009050
154. Corona, G., Mannucci, E., Petrone, L., Fisher, A. D., Balercia, G., Scisciolo, G. D., Pizzocaro, A., Giommi, R., Chiarini, V., Forti, G., & Maggi, M. (2006). Psychobiological Correlates of Delayed Ejaculation in Male Patients With Sexual Dysfunctions. Andrology. https://doi.org/10.2164/jandrol.05154
155. Corruble, E., Warot, D., & Soubrie, C. (2003). Insomnia linked to medications. SLEEP. https://doi.org/10.1007/978-1-4615-0217-3_20
156. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
157. Creasey, H., & Broe, G. A. (1993). Parkinson's disease. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.1993.tb137825.x
158. Crișan, C. A. (2018). Lack of Insight in Bipolar Disorder: The Impact on Treatment Adherence, Adverse Clinical Outcomes and Quality of Life. InTech eBooks. https://doi.org/10.5772/intechopen.76286
159. Crnic, K., Todorović, M., Marković, S., Kastratović, D., & Timotijevic, I. (2016). Addiction and depression comorbidity approaches. Hospital Pharmacology - International Multidisciplinary Journal. https://doi.org/10.5937/hpimj1603440c
160. Cruz, A. S. (2012). P-1458 - Postpartum psychosis: a case report. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75625-0
161. Cruz, S. L., & López, C. B. (2003). Fármacos que producen dependencia física y adicción. Avance y perspectiva.
162. Császár, N. (2014). The Importance of Psychological Assessment and Support in Patients Suffering from Cardiovascular Disease or Undergoing Cardiac Treatment. Journal of Cardiovascular Diseases & Diagnosis. https://doi.org/10.4172/2329-9517.1000161
163. Cuesta, J., & Singer, M. (2012). The stress response and critical illness. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e31826567eb
164. Cuijpers, P. (2010). Postpartum Depression. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0697
165. Cumberbatch, C.-J., Birndorf, C., & Dresner, N. (2006). Psychological implications of high-risk pregnancy.. International journal of fertility and women's medicine/International journal of fertility & women's medicine.
166. Cummings, J. L. (2007). The neuropsychiatric disturbances in demential disorders or behavioral and psychological symptoms of dementia As alterações neuropsiquiátricas nos transtornos demenciais ou sintomas psicológicos e comportamentais na demência.
167. Cunnington, D., Peters, A., & Greenwood, K. M. (2016). The need for psychological therapies for sleep disorders other than insomnia: potential for mindfulness.
168. Cupelli, R. H., Weise, A., Barbero, M., & Kool, J. (2017). Interim report: Development and evaluation of a three-week inpatient fatigue management education protocol for persons with MS-related fatigue.
169. Cvjetković-Bošnjak, M., Dubovski-Poslon, M., Bibić, Ž., & Bošnjak, K. (2019). The influence of chronic stress on health and coping mechanisms. SANAMED. https://doi.org/10.24125/sanamed.v14i1.293
170. Daley, D. C., & Douaihy, A. (2019). Psychiatric Illness Co-occurring with a Substance Use Problem. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0008
171. Daniele, A., & Albanese, A. (2012). Early visual memory deficits. Neurology. https://doi.org/10.1212/wnl.0b013e318253d67b
172. Darwish, L., Beroncal, E. L., Sison, M. V., & Swardfager, W. (2018). Depression in people with type 2 diabetes: current perspectives. Diabetes Metabolic Syndrome and Obesity. https://doi.org/10.2147/dmso.s106797
173. David, A. (2012). Investigation des fonctions mnésiques impliquées dans le processus de rémission de l'état de stress post-traumatique.
174. Davies, S., & Heyman, I. (2004). Psychiatric aspects. CRC Press eBooks. https://doi.org/10.1201/b13560-60
175. Delanerolle, G., Shetty, S., Raymont, V., Hapangama, D. K., Haque, N., Shi, J. Q., Ayis, S., Shetty, A., & Phiri, P. (2021). None. LOJ Medical Sciences. https://doi.org/10.32474/lojms.5.5
176. Delcea, C. (2019). Sexual deviances. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2019.12.119
177. Demey, I., Zimerman, M., Allegri, R., Serrano, C., & Taragano, F. (2004). Neuropsychiatric symptoms of mild cognitive impairment. CRC Press eBooks. https://doi.org/10.3109/9780203492857-7
178. Demirkol, M. E., & Tamam, L. (2016). Psikiyatrik Bozukluklarda Tedavi Uyumu Treatment Adherence in Psychiatric Disorders.
179. Derbyshire, S., & Bremner, J. D. (2009). Impact Of Functional Visceral And Somatic Pain/Stress Syndromes On Cingulate Cortex. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566960.003.0023
180. Derkach, T., Lifintseva, A. A., & Shtolde, N. (2018). Phenomenon of Uncertainty as a Subjective Experience. Clinical Psychology and Special Education. https://doi.org/10.17759/cpse.2018070101
181. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
182. Deses, C. D. D. L. (2018). Alteraciones del sueño en personas adultas mayores. Revista de la Facultad de Medicina (México).
183. Deutsch, A. R., Vargas, M., Lucchini, M., Brink, L., Odendaal, H. J., & Elliott, A. (2022). Effect of individual or comorbid antenatal depression and anxiety on birth outcomes and moderation by maternal traumatic experiences and resilience. Journal of Affective Disorders Reports. https://doi.org/10.1016/j.jadr.2022.100365
184. Dewi-Nurul, D.-N. M., & Hayatun-Safrina, H.-S. (2008). STRESS AS PREDISPOSING FACTOR OF SOME CHRONIC DISEASES INCLUDING PERIODONTAL DISEASE. Journal of Dentistry Indonesia. https://doi.org/10.14693/jdi.v13i1.272
185. Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., Chakraborty, S., Singh, K. P., Iqbal, H. M., Chaicumpa, W., & Joshi, S. K. (2019). Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2019.00091
186. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
187. Dickenson, D., & Fulford, B. (2001). Basic concepts: your myth or mine?. https://doi.org/10.1093/oso/9780192628589.003.0003
188. Diefenbach, G. J., & Goethe, J. W. (2006). Clinical interventions for late-life anxious depression. Clinical Interventions in Aging. https://doi.org/10.2147/ciia.2006.1.1.41
189. Dieterich, C. A., Snyder, N. D., & Villani, C. J. (2016). A legal study of children with emotional disturbance and mental health needs and implications for practice.. The Journal of Law of Education.
190. Djahnit, H., Mehdi, S., & Labidi, A. (2024). social and psychological problems experienced by people with chronic diseases in Algeria. International Journal of Health Sciences. https://doi.org/10.53730/ijhs.v8ns1.14694
191. Doblado, S. R., Zabala, M. B. E., Abascal, B. F., & Pelegrin, R. (2003). Síndrome depresivo en artritis reumatoide.
192. Dodel, R. (2010). Kognitive Störungen bei neurologischen Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628846
193. Donaghy, M., & Rossor, M. N. (2011). Psychologically determined disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198569381.003.0153
194. Donnoli, F., & Azari, M. F. (2013). Transition from acute to chronic low back pain: A biopsychosocial perspective. Chiropractic journal of Australia.
195. Donsu, J. D. (2016). Simtom Depresi dan Diabetes Mellitus: sebuah Comorbidity. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.22146/bpsi.11943
196. Doyle, A., & Pollack, M. H. (2003). Establishment of Remission Criteria for Anxiety Disorders. The Primary Care Companion To The Journal of Clinical Psychiatry.
197. Doyle, A., & Pollack, M. H. (2003). Establishment of remission criteria for anxiety disorders.. PubMed.
198. Dragoș, D., & Tănăsescu (2009). The critical role of psychosomatics in promoting a new perspective upon health and disease.. Journal of Medicine and Life.
199. Dray, A. (1995). Pathophysiology and Future Pharmacotherapy of Chronic Pain. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7218-8_26
200. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
201. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
202. Duffy, A., Jones, S., Goodday, S., & Bentall, R. P. (2015). Candidate Risks Indicators for Bipolar Disorder: Early Intervention Opportunities in High-Risk Youth. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyv071
203. Dugan, P., Holmes, M., & Carlson, C. (2025). Cognitive and Behavioral Issues. Epilepsy. https://doi.org/10.1093/med/9780197673751.003.0029
204. Dugue, M., & Neugroschl, J. (2002). Anxiety disorders. Helping patients regain stability and calm.. PubMed.
205. Dunn, K. M., & Croft, P. (2004). Epidemiology and natural history of low back pain.. PubMed.
206. Durán, L. V. B., González, M., & Álvarez, G. B. (2020). Trastorno por estrés postrauma. Revista Medica Sinergia. https://doi.org/10.31434/rms.v5i9.568
207. Durán, L. V. B., Navarrete, K. S. H., & Salas, M. F. (2023). Actualización del trastorno dismórfico corporal. Revista Medica Sinergia. https://doi.org/10.31434/rms.v8i2.967
208. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
209. Dziegielewski, S. F. (2014). Depressive Disorders. https://doi.org/10.1002/9781394260577.ch7
210. D’Souza, R. S., & Hooten, W. M. (2019). Somatic Syndrome Disorders.
211. Ebenezer, I. S. (2015). Affective Disorders 1: Depression. https://doi.org/10.1002/9781118385777.ch6
212. Ebzeeva, E. Y., & Polyakova, O. A. (2022). Stress and stress-induced disorders. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2022-16-2-127-133
213. Efron, D., & Freeman, J. L. (2018). Medical cannabis for paediatric developmental–behavioural and psychiatric disorders. Journal of Paediatrics and Child Health. https://doi.org/10.1111/jpc.13902
214. Efthimiou, K., & Mitsi, C. (2015). [Infertility: psychological-psychopathological consequences and cognitive-behavioural interventions].. PubMed.
215. Egbert, A. M. (1993). 'The dwindles'. Failure to thrive in older patients.. PubMed.
216. Eisendrath, S. J. (1995). Psychiatric aspects of chronic pain. Neurology. https://doi.org/10.1212/wnl.45.12_suppl_9.s26
217. El-Bidawy, M. H. (2018). Pathophysiological Changes Occuring in Cardiovascular and Immune Systems In Response to Stress. International Journal of Sciences: Basic and Applied Research.
218. El-Radhi, A. S. (2015). Management of common behaviour and mental health problems. British Journal of Nursing. https://doi.org/10.12968/bjon.2015.24.11.586
219. Elena, M. J. S. (2014). Influencia de los estilos de personalidad y de afrontamiento en la satisfacción con la vida de personas con enfermedades crónicas, insuficiencia renal crónica, artritis reumatoide y espondilitis anquilosante.
220. Elhwuegi, A., & Lamis, A. (2018). None. Libyan International Medical University Journal. https://doi.org/10.1055/s-012-53533
221. Elkholy, H., Elgawad, A. A. A., Bendi, N., & Beezhold, J. (2016). Managing psychiatric emergencies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198723646.003.0017
222. Emilien, G., Durlach, C., Minaker, K. L., Winblad, B., Gauthier, S., & Maloteaux, J. (2004). Behavioral and psychological impairments. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7842-5_9
223. Emmett, S. R., Hill, N. A., & Dajas‐Bailador, F. (2019). Psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199694938.003.0018
224. Enman, N. M., Sabban, E. L., McGonigle, P., & Bockstaele, E. J. V. (2014). Targeting the neuropeptide Y system in stress-related psychiatric disorders. Neurobiology of Stress. https://doi.org/10.1016/j.ynstr.2014.09.007
225. Ensalada, L. (2011). Behavioral Factors Impact Impairment and Disability Evaluation. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2011.sepoct03
226. Ensalada, L. H., Brigham, C. R., & Kertay, L. (2018). Somatization. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2018.julaug03
227. Escobedo, A. D. Á. (2012). Influencia del estrés y depresión prenatal en el desarrollo del niño. Revista Peruana de Pediatría. https://doi.org/10.61651/rped.2012v65n3p158-169
228. Espinel, Z., & Shaw, J. A. (2018). PTSD in Children. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259440.003.0012
229. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
230. Eugenio, A. L. (2017). Depresión y factores de riesgo cardiovasculares en enfermedad de Parkinson: signos de alarma (fragilidad) en la séptima década de la vida. Proyecto de investigación:.
231. Evers, M. M., & Marin, D. B. (2002). Mood disorders. Effective management of major depressive disorder in the geriatric patient.. PubMed.
232. Fabra, M. (2002). [So-called trauma criterium (a criterium of DSM-IV) in posttraumatic stress disorder and its significance for social and legal insurance (I)].. PubMed.
233. Falkai, P., Malchow, B., & Schmitt, A. (2013). Neurobiological Background of Affective Disorders. InTech eBooks. https://doi.org/10.5772/51801
234. Farina, B., Liotti, M., & Imperatori, C. (2019). The Role of Attachment Trauma and Disintegrative Pathogenic Processes in the Traumatic-Dissociative Dimension. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2019.00933
235. Fava, G. A., & Visani, D. (2008). Psychosocial determinants of recovery in depression. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.4/gafava
236. Fava, G. A., & Visani, D. (2008). Psychosocial determinants of recovery in depression.. PubMed.
237. Fava, G. A., Guidi, J., Semprini, F., Tomba, E., & Sonino, N. (2010). Clinical Assessment of Allostatic Load and Clinimetric Criteria. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000318294
238. Favre, P. (2014). Dysfonctionnement fronto-limbique dans le trouble bipolaire et apports des interventions thérapeutiques psychosociales : approche par l'IRM multimodale.
239. Fazel, M., Reed, R. V., & Goldring, L. (2012). Post-traumatic stress disorder. BMJ. https://doi.org/10.1136/bmj.e3790
240. Fernandes, C. E., Ferreira, J. A. D. S., Azevedo, L. H. D., Pellini, E. A. J., & Peixoto, S. V. (2004). Síndrome da tensão pré-menstrual – o estado atual dos conhecimentos. Arquivos Médicos do ABC.
241. Fernandez, H. H., & Simuni, T. (2007). Anxiety. Humana Press eBooks. https://doi.org/10.1385/1-59259-859-5:13
242. Fernández, F., Boon-How, Chew, Sazlina, Shariff-Ghazali, & Aarón (2014). Psychological aspects of diabetes care: Effecting behavioral change in patients. 世界糖尿病杂志：英文版（电子版）.
243. Ferreira, P., Martins, A., & Silva, A. (2010). P02-256 - When Psychiatric Action is Limited: Cases of Personality Disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70882-8
244. Fishbain, D. A. (1999). APPROACHES TO TREATMENT DECISIONS FOR PSYCHIATRIC COMORBIDITY IN THE MANAGEMENT OF THE CHRONIC PAIN PATIENT. Medical Clinics of North America. https://doi.org/10.1016/s0025-7125(05)70132-2
245. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
246. Fleming, A. M., & Eisendrath, S. J. (2015). Somatic Symptom and Related Disorders: Factitious Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch63
247. Flynn, K. E., Piña, I. L., Whellan, D. J., Lin, L., Blumenthal, J. A., Ellis, S. J., Fine, L. J., Howlett, J. G., Keteyian, S. J., Kitzman, D. W., Kraus, W. E., Miller, N. H., Schulman, K. A., Spertus, J. A., O’Connor, C. M., & Weinfurt, K. P. (2009). Effects of Exercise Training on Health Status in Patients With Chronic Heart Failure. JAMA. https://doi.org/10.1001/jama.2009.457
248. Foa, E. B., Stein, D. J., & McFarlane, A. C. (2006). Symptomatology and psychopathology of mental health problems after disaster.. PubMed.
249. Fonseca, R. S. D., Nazaré, G. O. D., Silva, P. S. L. D., Fortes, G. N., & Lemos, A. L. (2017). SINTOMAS DEPRESSIVOS EM ACADÊMICOS DE UMA UNIVERSIDADE PÚBLICA NO OESTE DO ESTADO DO PARÁ, RELATO DE EXPERIÊNCIA. 13º Congresso Internacional Rede Unida.
250. Forbes, F. (2010). Improving recognition and management of ADHD.. Practitioner.
251. Fournier, A.-L. (2012). Carnets de campagne – 1. Santé mentale.
252. Frankenburg, F. R., & Zanarini, M. C. (2006). Personality disorders and medical comorbidity. Current Opinion in Psychiatry. https://doi.org/10.1097/01.yco.0000228766.33356.44
253. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
254. Fricchione, G. L., Esch, T., Joos, S., & Teut, M. (2013). Self-Care, Stress Management, and Primary Care: From Salutogenesis and Health Promotion to Mind-Body Medicine. Evidence-based Complementary and Alternative Medicine. https://doi.org/10.1155/2013/327415
255. Friedland, D., & Swash, M. (2016). Post-traumatic amnesia and confusional state: hazards of retrospective assessment. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2015-312193
256. Fries, W. (2013). Verhaltensstörungen nach Frontalhirnschädigung. neuroreha. https://doi.org/10.1055/s-0033-1347961
257. Fritzsche, K., Monsalve, S. D., Frahm, G., Afshar, H., Goli, F., Goli, F., & Chen, F. K.-Y. (2014). Psycho-Cardiology. Psychosomatic Medicine. https://doi.org/10.1007/978-1-4614-1022-5_13
258. Frommberger, D.-B. U. (2014). In Reply. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489c
259. Fullwood, A., & Drossman, D. A. (1995). THE RELATIONSHIP OF PSYCHIATRIC ILLNESS WITH GASTROINTESTINAL DISEASE. Annual Review of Medicine. https://doi.org/10.1146/annurev.med.46.1.483
260. Gabryelewicz, T. (2007). Zaburzenia zachowania oraz zaburzenia psychotyczne i afektywne w otępieniu.
261. Gabryelewicz, T. (2014). [Pharmacological treatment of behavioral symptoms in dementia patients].. PubMed.
262. Gaffey, A. E., & Martinez, B. S. (2019). Neuroendocrine Mechanisms of Psychological Stress: Age and Sex Differences in Adults. Oxford Research Encyclopedia of Neuroscience. https://doi.org/10.1093/acrefore/9780190264086.013.280
263. Gaffey, A. E., Goldstein, C. M., Hays, M. M., Lee, S. Y., & Gaalema, D. E. (2023). Psychological Risk Factors in Cardiac Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention. https://doi.org/10.1097/hcr.0000000000000828
264. Gainotti, G. (1993). Emotional and psychosocial problems after brain injury. Neuropsychological Rehabilitation. https://doi.org/10.1080/09602019308401440
265. Gameiro, G. R., Minguini, I. P., & Alves, T. C. T. F. (2014). O papel do estresse e de acontecimentos cotidianos para o desenvolvimento da depressão na terceira idade. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v93i1p31-40
266. Gani, H. (2016). Risk Factors: Pathogenesis, Diagnosis and Management of Delirium. International Journal of Science and Research (IJSR). https://doi.org/10.21275/v5i4.nov162972
267. Gankina, O. A. (2017). Neuropsychiatric disorders in dementia: mechanisms and treatment approach. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20171176258-65
268. Garay, M. A., Richards, S., Mj, M. U., & Luguercho, C. (2007). [Psychotic major depressive episode: target symptoms in males and females].. PubMed.
269. Gaszner, G., Barna, G., & Döme, P. (2017). [About the association between antipsychotic medication and cardiovascular morbidity: epidemiology and possible background mechanisms].. PubMed.
270. Gautam, S., Gautam, M., Yadav, K. S., Chaudhary, J., & Jain, A. (2023). Clinical Practice Guidelines for Assessment and Management of Aggressive and Assaultive Behaviour. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_518_22
271. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
272. Geraghty, K. (2020). The negative impact of the psychiatric model of chronic fatigue syndrome on doctors’ understanding and management of the illness. Fatigue Biomedicine Health & Behavior. https://doi.org/10.1080/21641846.2020.1834295
273. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
274. Geuze, R. H. (2016). Motorische ontwikkelingsstoornissen: DCD en dyspraxie.
275. Ghoneim, M. M., & Block, R. I. (2012). Clinical, methodological and theoretical issues in the assessment of cognition after anaesthesia and surgery. European Journal of Anaesthesiology. https://doi.org/10.1097/eja.0b013e328356bd6e
276. Giallauria, F., Battimiello, V., Veneziano, M., Luca, P. D., Cipollaro, I., Buonincontro, M., Vigorito, C., & Forno, D. D. (2016). Psychosocial risk factors in cardiac practice. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2007.455
277. Giannoglou, G. D., & Koskinas, K. C. (2014). Mental Stress and Cardiovascular Disease. Angiology. https://doi.org/10.1177/0003319714525032
278. Giannuzzi, R., Testa, A. C., Sollazzo, F., Petrongolo, L., Bernardini, L., & Daini, S. (2013). Psychiatric emergencies (part I): psychiatric disorders causing organic symptoms.. PubMed.
279. Gibson, G. S., & Benson, F. B. (1979). SOMATOPSYCHIC EFFECTS OF HYPERTENSION: A THEORETICAL POSITION. Social Behavior and Personality An International Journal. https://doi.org/10.2224/sbp.1979.7.2.167
280. Gidal, B. E., & Barry, J. J. (2006). Sexual Dysfunction in Patients with Neuropsychiatric Disorders: Challenges and Opportunities. CNS Spectrums. https://doi.org/10.1017/s1092852900026699
281. Gifensius, J., Ganesha, I. G. H., Sundariyati, I. G. A. H., Tjandra, D. C., & Dewayani, I. A. P. (2024). THE INFLUENCE OF MENTAL HEALTH DISORDERS ON THE STUDENT COMPETENCY TEST FOR MEDICAL PROFESSIONAL PROGRAM (UKMPPD) RESULTS AT UDAYANA UNIVERSITY. E-Jurnal Medika Udayana. https://doi.org/10.24843/mu.2024.v13.i11.p17
282. Ginting, D. A., Jayady, A., Habibi, M. M., Andarmoyo, S., & Irawan, A. (2020). Mental health problems in covid-19 situation. European Journal of Molecular & Clinical Medicine.
283. Gioacchino, M. D., Boscolo, P., Reale, M., Muraro, R., & Giampaolo, L. D. (2011). Work stress and innate immune response.. International Journal of Immunopathology and Pharmacology.
284. Giordano, G. M., Brando, F., Pezzella, P., Angelis, M. D., Mucci, A., & Galderisi, S. (2022). Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.970210
285. Glassford, J. A. G. (2017). The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Frontiers in Physiology. https://doi.org/10.3389/fphys.2017.00088
286. Gledhill, J., Boisvert, C., & Thinlot, C. (2006). Management of fatigue in oncology. La Revue du praticien.
287. Gloth, F. M. (1996). Concerns with chronic analgesic therapy in elderly patients. The American Journal of Medicine. https://doi.org/10.1016/s0002-9343(96)00134-9
288. Glăvan, D., Stănia, B., Pîrlog, M. C., & Udriștoiu, I. (2018). Factori sociodemografici implicaţi în evoluţia depresiei monitorizate în ambulatoriu. Psihiatru ro.
289. Glăvan, D., Stănia, B., Pîrlog, M. C., & Udriștoiu, I. (2018). Socio-demographic factors involved in the evolution of depression monitored in outpatient unit. Psihiatru ro. https://doi.org/10.26416/psih.51.4.2017.1362
290. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
291. Golden, G. S. (1979). The Effect of Developmental Disabilities on Mental Health. Journal of School Health. https://doi.org/10.1111/j.1746-1561.1979.tb03847.x
292. Goldman, H. H., & Grob, G. N. (2006). Defining 'Mental Illness' In Mental Health Policy Diagnosis does not efficiently measure the need for treatment; we have better methods for managing scarce resources..
293. Golightly, L., & Young, A. H. (1999). Sex hormones and mental health. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.5.2.126
294. González, A. (2005). Fisiopatología y diagnóstico de la anorexia nerviosa y la bulimia.
295. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la picofarmacología al trataamiento de los trastornos de la personalidad (II): grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad. EduPsykhé: Revista de psicología y psicopedagogía.
296. González, C., Betés, M., López‐Muñoz, F., & Martín, J. D. D. M. (2011). Aportaciones de la psicofarmacología al tratamiento de los trastornos de la personalidad (II) = Contributions of psychopharmacology for the treatment of personality disorders (II: grupos farmacológicos empleados en el tratamiento de los trastornos de personalidad = pharmacological groups employed in the treatment of the disorders of personality /. Edupsykhé Revista de Psicología y Educación. https://doi.org/10.57087/edupsykhe.v10i2.3852
297. González, S. M. B., Campoy, A. T., Carballeda, J. M., Pastorelli, R. V., & Vallejo, J. V. G. (2011). ¿Manía vs psicosis tóxica vs trastornos de conducta? A propósito de un caso.. Psiquiatria.com.
298. Gooblar, J., & Beaudreau, S. A. (2018). Anxiety Disorders in Late Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.415
299. Goodwin, G. M. (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
300. Grachev, I. D. (2013). Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2013-305380
301. Graeber, B., Soufer, A., Burg, M. M., & Soufer, R. (2007). The Implications of Mental Stress for Cardiovascular Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-096-6_11
302. Graham, D. (1967). Health, Disease, and the Mind-Body Problem: Linguistic Parallelism. Psychosomatic Medicine. https://doi.org/10.1097/00006842-196701000-00006
303. Gram, L. F., Brøsen, K., Sindrup, S. H., & Skjelbo, E. (1993). Risk factors in elderly taking psychotropic drugs: Significance of genetic polymorphism in drug oxidation. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489309102787
304. Granger, C. E., & Shelly, M. P. (1996). Stressing out, or outing stress?. European Journal of Anaesthesiology. https://doi.org/10.1097/00003643-199611000-00001
305. Greenblatt, D. J., Shader, R. I., & Löfgren, S. (1976). Rational Psycho-Pharmacology for Patients with Medical Diseases. Annual Review of Medicine. https://doi.org/10.1146/annurev.me.27.020176.002203
306. Gründer, G. (2006). Remission bei Depression erreichen. psychoneuro. https://doi.org/10.1055/s-2006-934199
307. Guadagnoli, L., Knowles, S. R., & Keefer, L. (2017). Patient empowerment and working with complex patients with functional gastrointestinal disorders. Routledge eBooks. https://doi.org/10.4324/9781315670355-25
308. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
309. Guiraud, V., & Touzé, E. (2013). Psychological and Psychiatric Triggers and Risk Factors for Stroke. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-1-4471-2428-3_12
310. Gunatilake, S., Ananth, J., Parameswaran, S., Brown, S., & Silva, W. L. B. D. (2004). Rehabilitation of Schizophrenic Patients. Current Pharmaceutical Design. https://doi.org/10.2174/1381612043384141
311. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
312. Guthrie, M., Zubatsky, M., & Smith, C. W. (2015). Family Stress and Counseling. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_30-1
313. Gómez‐Revuelta, M., Blanco, L. S., Ruíz, M. J., Jenaro, G. P. D. S., Rodríguez, R. L., Olivares, O. P., & Morales, N. N. (2017). A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.577
314. Haass, M., & Albus, C. (2014). Psychosoziale Faktoren bei Herzinsuffizienz: Mehr als eine Komorbidität?. Kardiologie up2date. https://doi.org/10.1055/s-0034-1365137
315. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
316. Haesebaert, F. (2014). Dépression résistante : vers une prise en considération des comorbidités et de la iatrogénie. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.051
317. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
318. Hammerman, O., Ifergane, G., & Ezra, Y. (2017). [PSYCHO-MEDICAL ASPECTS OF PRIMARY HEADACHES].. PubMed.
319. Hansch, D. (2019). Angst und psychosomatische Erkrankungen: Eskalationsmechanismen und therapeutische Strategien aus der Sicht von Systemtheorie und Verhaltenstherapie. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a001091
320. Harrington, J., Spurgeon, A., & Gompertz, D. (1996). Modifiers ofnon-specific symptomsin occupational andenvironmental syndromes.
321. Hartman, T. O., Woutersen-Koch, H., & Horst, H. E. V. D. (2013). Medically unexplained symptoms: evidence, guidelines, and beyond. British Journal of General Practice. https://doi.org/10.3399/bjgp13x675241
322. Hasanat, N. U., & Ma, S. (2015). Pengembangan Modul untuk Meningkatkan Emosi Positif Pasien di Rumah Sakit. Buletin Psikologi. https://doi.org/10.22146/bpsi.7446
323. Hashizume, M. (2011). Psychosomatic approach for chronic migraine. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.51.1153
324. Hassan, H. M., Ahmed, A., Othman, M., El-said, M. A. A. E., Elgendy, E., Galal, S. A., Barakat, N. O., Elfakhry, B., Khan, R. B., Ali, A., Kamal, A., & Ezzeldin, S. (2022). Emotional Impact; the magic bullet in influencing chronic diseases. Delta University Scientific Journal. https://doi.org/10.21608/dusj.2022.233890
325. He, W., Shao, L., Wang, H., Huang, H., Zhang, S., Li, C., Zhang, C., & Yi, W. (2022). Bilateral Anterior Capsulotomy for the Treatment of Refractory Somatic Symptom Disorder: A Case Report. Frontiers in Integrative Neuroscience. https://doi.org/10.3389/fnint.2021.721833
326. Hellhammer, D. H., & Wade, S. E. (1993). Endocrine Correlates of Stress Vulnerability. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288675
327. Henningsen, P. (2018). Somatic Symptom Disorder and Illness Anxiety Disorder. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl11
328. Henry, L. A., Messer, D., & Poloczek, S. (2018). Working Memory and intellectual disabilities. Routledge eBooks. https://doi.org/10.4324/9781315302072-2
329. Hickam, J. B., Cargill, W. H., & Golden, A. (1948). CARDIOVASCULAR REACTIONS TO EMOTIONAL STIMULI. EFFECT ON THE CARDIAC OUTPUT, ARTERIOVENOUS OXYGEN DIFFERENCE, ARTERIAL PRESSURE, AND PERIPHERAL RESISTANCE 1. Journal of Clinical Investigation. https://doi.org/10.1172/jci101946
330. Hidayat, L. S., & Kristiana, I. F. (2023). Religiosity and Mental Health: A Case Study. Proceedings of International Conference on Psychological Studies (ICPsyche). https://doi.org/10.58959/icpsyche.v4i1.59
331. Hoffmann, F., & Heim, C. (2024). Emotionaler Missbrauch in Kindheit und Jugend – Biologische Einbettung und klinische Implikationen. Praxis der Kinderpsychologie und Kinderpsychiatrie. https://doi.org/10.13109/prkk.2024.73.1.4
332. Holl, J., & Barnow, S. (2017). Relevance of Functional Emotion Regulation Processes for Sustaining Mental Health After History of Early Psychological Trauma. Journal of Trauma & Treatment. https://doi.org/10.4172/2167-1222.1000369
333. Holster, J., Hawks, E. M., & Ostermeyer, B. (2017). Somatic Symptom and Related Disorders. Psychiatric Annals. https://doi.org/10.3928/00485713-20170308-03
334. Homberg, J. R., & Contet, C. (2009). Deciphering the Interaction of the Corticotropin-Releasing Factor and Serotonin Brain Systems in Anxiety-Related Disorders: Figure 1.. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.4362-09.2009
335. Hong, C. (2013). 분과 심포지움 2. 임상 : 새로운 진단체계 DSM-5; 조현병 스펙트럼 및 기타 정신병적 장애,성격장애. 한국심리학회 연차 학술발표논문집.
336. Hong, C. (2013). 조현병 스펙트럼 및 기타 정신병적 장애, 성격장애. 한국심리학회 학술대회 자료집.
337. Hopko, D. R., McIndoo, C. C., & File, A. A. (2016). Depressive Syndromes and Medical Comorbidities. https://doi.org/10.1093/oxfordhb/9780199973965.013.30
338. Hosang, G. M., Korszun, A., Jones, L., Jones, I., McGuffin, P., & Farmer, A. (2012). Life-event specificity: bipolar disorder compared with unipolar depression. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.bp.112.111047
339. House, A. (1996). Depression associated with stroke. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.8.4.453
340. Howells, J. (1982). The Meeting of Patient and Doctor. https://doi.org/10.1007/978-1-349-16817-0_4
341. Howse, J., Iqbal, S. M. Z., Banu, S., Lateef, A., Khan, S., Barlas, Z., Moon, S.-H., Moukaddam, N., & Shah, A. A. (2024). The Effects of Stress on Health. Psychiatric Annals. https://doi.org/10.3928/00485713-20241004-02
342. Huda, A. S. (2019). Biological factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0012
343. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
344. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
345. Huda, A. S. (2019). Treatments in psychiatry compared to general medicine. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0015
346. Hughes, M. M., Connor, T. J., & Harkin, A. (2016). Stress-Related Immune Markers in Depression: Implications for Treatment. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyw001
347. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
348. Ignatova, E. S., Bogaevskaya, O. U., & Yumashev, A. V. (2021). Psychodiagnostics as a mandatory element of patient protocols in dentistry. Journal of International Society of Preventive and Community Dentistry. https://doi.org/10.4103/jispcd.jispcd_60_21
349. Impey, B., Gordon, R. P., & Baldwin, D. S. (2020). Anxiety disorders, post-traumatic stress disorder, and obsessive–compulsive disorder. Medicine. https://doi.org/10.1016/j.mpmed.2020.08.005
350. In-Albon, T. (2012). Supplementary Material for: Aktueller Stand Internalisierender Störungen im Kindes- und Jugendalter: Sind sie aus den Kinderschuhen ausgewachsen?. Figshare. https://doi.org/10.6084/m9.figshare.5124268
351. Irgebaeva, N., & Akmusaeva, M. (2020). ANXIETY OF THE PERSONEMOTIONAL STATUS. BULLETIN Series Psychology. https://doi.org/10.51889/2020-3.1728-7847.04
352. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
353. Ishizuka, K., Shikino, K., Li, Y., Yokokawa, D., Tsukamoto, T., Yanagita, Y., Kojima, J., Yamashita, S., Noda, K., Uehara, T., & Ikusaka, M. (2023). The differential diagnosis of medical and psychogenic disease in primary care. Journal of General and Family Medicine. https://doi.org/10.1002/jgf2.661
354. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
355. Jablensky, A. (2012). Course and outcome of schizophrenia and their prediction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0078
356. Jafferany, M., & Pastolero, P. (2018). Psychiatric and Psychological Impact of Chronic Skin Disease. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.17nr02247
357. Jain, R. K., & Webb, D. R. (2016). Chronic pain : addressing the triad of pain, sleep and depression/anxiety : original. South African Journal of Diabetes.
358. Jakl, M., Skořepa, P., & Horáček, J. M. (2016). IMPACT OF EXTREME PHYSICAL EXERCISE ON HUMAN BODY. Military Medical Science Letters. https://doi.org/10.31482/mmsl.2016.026
359. Jenike, M. A. (1996). Psychiatric Illnesses in the Elderly: A Review. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198879600900202
360. Jevtovic, J., Jovanović, J., Grujicic, M. V. –., & Vujcic, J. (2021). OCCUPATIONAL STRESS IN COMPUTER OPERATORS. Knowledge International Journal.
361. Jiménez, E. S. D. (2019). Neurocognición y resultado funcional en el trastorno bipolar con síntomas psicóticos.
362. Jones, S., Howard, L. M., & Thornicroft, G. (2008). ‘Diagnostic overshadowing’: worse physical health care for people with mental illness. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.2008.01211.x
363. Jorge, T. P. C. (2012). Fisiopatología del dolor agudo: alteraciones cardiovasculares, respiratorias y de otros sistemas y órganos.
364. Juckel, G. (2014). [Psychiatric disorders and their effects on mortality and morbidity].. PubMed.
365. Jukić, M. K., & Mimica, N. (2012). Demented syndrome and other mental disorders in patients with Parkinson's disease.
366. Järvholm, S. (2022). [Psychological aspects of infertility].. PubMed.
367. Kalashnyk, D. O. (2025). Психоемоційний статус як фактор ризику розвитку бруксизму: мультидисциплінарний підхід до діагностики і лікування. Likarska sprava. https://doi.org/10.31640/ls-2025-3-03
368. Kales, H. C., & Valenstein, M. (2002). Complexity in Late-Life Depression: Impact of Confounding Factors on Diagnosis, Treatment, and Outcomes. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/089198870201500306
369. Kanbara, K., & Morita, Y. (2020). Stress assessment by psychophysiological monitoring in daily life. Impact. https://doi.org/10.21820/23987073.2020.7.70
370. Kancherla, N., Vanka, S. C., Pokhrel, S., Shahzadi, R. B., & Pradeep, G. V. D. (2022). The Development of Illness Anxiety Disorder in a Patient After Partial Thyroidectomy. Cureus. https://doi.org/10.7759/cureus.25416
371. Kanner, A. M. (2012). Poststroke Depression. https://doi.org/10.1002/9781118348093.ch10
372. Kapur, N., & Goldney, R. D. (2019). Psychiatric disorders and biological factors. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198791607.003.0005
373. Katz, I. R. (1999). Depression in late life: psychiatric-medical comorbidity. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.1999.1.2/ikatz
374. Katz, R. T., & Smith, S. L. (2008). Pain Disorders, Part II: Evaluating the Difficult Pain Patient. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2008.julaug02
375. Kavan, M., Elsasser, G. N., & Barone, E. J. (2012). The physician's role in managing acute stress disorder.. PubMed.
376. Kazymova, N., Kharlamenkova, N. Y., & Nikitina, D. A. (2019). Severe life events and their psychological consequences: loss or threat of loss of nearest. Vestnik Kostroma State University Series Pedagogy Psychology Sociokinetics. https://doi.org/10.34216/2073-1426-2019-25-2-96-101
377. Keller, M. B. (2004). Remission versus response: the new gold standard of antidepressant care.. PubMed.
378. Kelly, B., & Turner, J. (2009). Depression in advanced physical illness: diagnostic and treatment issues. The Medical Journal of Australia. https://doi.org/10.5694/j.1326-5377.2009.tb02478.x
379. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
380. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
381. Kerna, N. A., Pruitt, K. D., Olaniru, F. O., Flores, J. V., Nwafor, B. N., Ngwu, D. C., Keke, C. O., Holets, H. M., McKee, D., Jomsky, B. M., Carsrud, N. V., & Anderson, J. (2024). Impact of Medication Nonadherence Across Medical Specialties: Effects on Clinical Outcomes, Physician Satisfaction, and Socioeconomic Factors with Tools for Mitigation. European Journal of Medical and Health Research. https://doi.org/10.59324/ejmhr.2024.2(6).16
382. Khademi, K., Dadkhah, A., & Kazemi, V. (2012). Body Part Concerns Questionnaire (BPCQ) in an Iranian Population with Special Needs. Iranian Rehabilitation Journal.
383. Khan, A. Y., Kalia, R., Ide, G. D., & Ghavami, M. (2017). What Are Realistic Treatment Goals? Lingering Symptoms Require You to Evaluate Pharmacotherapy and Offer Psychosocial Interventions. Current psychiatry.
384. Kiecolt‐Glaser, J. K., & Glaser, R. (2001). Stress and Immunity: Age Enhances the Risks. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00105
385. Kiecolt‐Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015). Inflammation: Depression Fans the Flames and Feasts on the Heat. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2015.15020152
386. Kiecolt‐Glaser, J. K., Renna, M. E., Shrout, M. R., & Madison, A. A. (2020). Stress Reactivity: What Pushes Us Higher, Faster, and Longer—and Why It Matters. Current Directions in Psychological Science. https://doi.org/10.1177/0963721420949521
387. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
388. Kim, J. S. (2016). Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms. Journal of Stroke. https://doi.org/10.5853/jos.2016.01144
389. Kisely, S. (2023). Periodontal Health and Psychiatric Disorders. Current Oral Health Reports. https://doi.org/10.1007/s40496-023-00339-y
390. Kitaoka, S., Nie, X., Tanaka, K., Ogawa, A., Segi‐Nishida, E., Narumiya, S., & Furuyashiki, T. (2019). Repeated stress-induced behavioral changes and inflammation-like responses. Proceedings for Annual Meeting of The Japanese Pharmacological Society. https://doi.org/10.1254/jpssuppl.92.0_1-ys-2
391. Klassen-Bolding, S., & Lenz, A. S. (2016). Post-traumatic Stress Disorder in Youth. https://doi.org/10.63134/mwtw7144
392. Knapp, P., & Lightbody, C. E. (2019). Emotional and Cognitive Changes Following a Stroke. https://doi.org/10.1002/9781119581161.ch11
393. Kondo, K., Low, A., Jindai, K., Mendelson, A., Motu’apuaka, M., Mansoor, D., Judge, M., Kansagara, D., Freeman, M., & Hartung, D. M. (2015). Interventions to Improve Pharmacological Adherence Among Adults with Psychotic Spectrum Disorders, Bipolar Disorder, and Posttraumatic Stress Disorder.
394. Kononova, O., & Borysenko, A. (2022). Роль психоемоційного стресу в розвитку стоматологічних захворювань. Терапевтика. https://doi.org/10.31793/2709-7404.2021.2-4.33
395. Kop, W. J. (1999). Chronic and Acute Psychological Risk Factors for Clinical Manifestations of Coronary Artery Disease. Psychosomatic Medicine. https://doi.org/10.1097/00006842-199907000-00012
396. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
397. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
398. Kotowicz, K., Gawęda, Ł., Misiak, B., & Frydecka, D. (2020). The role of the cognitive biases along the psychosis continuum: from pathophysiology to treatment options. Archives of Psychiatry and Psychotherapy. https://doi.org/10.12740/app/130365
399. Kovács, P., Pánczél, G., Melegh, K., Balatoni, T., Pörneczy, E., Lõrincz, L., Czirbesz, K., Gorka, E., & Liszkay, G. (2016). [Psychological aspects of immunotherapies in the treatment of malignant melanoma].. PubMed.
400. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
401. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2007). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b14442-26
402. Kroenke, K. (2020). Two Birds with One Stone: Joint Screening for Perinatal Depression and Anxiety. Journal of Women s Health. https://doi.org/10.1089/jwh.2020.8643
403. Krolak‐Salmon, P., & Thomas-Antérion, C. (2010). Fonctions exécutives, attention et mémoire de travail au cours du vieillissement. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2010.0072
404. Kronenberg, G., & Endres, M. (2013). Schlaganfall und Psyche. Aktuelle Neurologie. https://doi.org/10.1055/s-0033-1354353
405. Kuch, K. (2001). Psychological Factors and the Development of Chronic Pain. Clinical Journal of Pain. https://doi.org/10.1097/00002508-200112001-00009
406. Kumari, V. (2021). New insights on affective morbidity and childhood maltreatment. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.121
407. Kutlubaev, M. A. (2017). Depression and depression-related disorders after a subarachnoid hemorrhage. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro20171178220-26
408. Kırca, N., & Öngen, M. (2020). İNFERTİLİTE VE UYKU KALİTESİ ARASINDAKİ İLİŞKİ. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. https://doi.org/10.38136/jgon.697603
409. Lam, R. W. (2018). Associated clinical features. Depression. https://doi.org/10.1093/med/9780198804147.003.0005
410. Lam, R. W. (2018). Clinical features and diagnosis. Depression. https://doi.org/10.1093/med/9780198804147.003.0004
411. Lambert, M., Schimmelmann, B. G., Karow, A., & Naber, D. (2003). Subjective Well-being and Initial Dysphoric Reaction under Antipsychotic Drugs - Concepts, Measurement and Clinical Relevance. Pharmacopsychiatry. https://doi.org/10.1055/s-2003-45128
412. Lamy, P. P. (1979). Considerations in Drug Therapy of the Elderly. Journal of Drug Issues. https://doi.org/10.1177/002204267900900103
413. Larrea, S. T., Fernández‐Aranda, F., Jiménez‐Múrcia, S., & Granero, R. (2016). Nuevos retos en el tratamiento de los trastornos relacionados con la impulsividad.
414. Lassal, R., Laurent, M., & Purper‐Ouakil, D. (2011). [Early signs of mental disorders in children aged 3-12 years].. PubMed.
415. Latas, M., Jerotić, S., Tiosavljević, D., & Lačković, M. (2023). Separation Anxiety Disorder: Is There a Justification for a Distinct Diagnostic Category?. Mind Brain and Education. https://doi.org/10.1007/978-3-031-33013-1_7
416. Lawlor, B. (2004). Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.. PubMed.
417. Leclair, N., Leclair, S., & Brigham, C. R. (2002). Multiaxial Diagnosis of Mental and Behavioral Disorders. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2002.novdec01
418. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
419. Leuchtmann, L., & Bodenmann, G. (2017). Interpersonal view on physical illnesses and mental disorders. Swiss Archives of Neurology Psychiatry and Psychotherapy. https://doi.org/10.4414/sanp.2017.00516
420. Levenson, J. L. (2008). Psychological Factors Affecting Medical Condition. Psychiatry. https://doi.org/10.1002/9780470515167.ch83
421. Levi, L. (1987). Society, Brain and Gut—A Psychosocial Approach to Dyspepsia. Scandinavian Journal of Gastroenterology. https://doi.org/10.3109/00365528709090979
422. León, M. S. M. D. (2017). Trastorno por déficit de atención con hiperactividad: autorregulación emocional y funciones ejecutivas.
423. Li, M., Rosenblat, J. D., & Rodin, G. (2018). Depression. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl07
424. Li, Y., Wei, D., Sun, J., Meng, J., Ren, Z., He, L., Zhuang, K., & Qiu, J. (2019). [Personality and depression: A review of theory model and behavior and neural mechanism].. PubMed.
425. Lidz, C. W., Grisso, T., Albert, K., & Smith, K. C. (2004). Violence and People with Mental Illness Served in the Public Mental Health System. Psychiatry Information in Brief. https://doi.org/10.7191/pib.1038
426. Lieberman, P. B. (2017). A Case of Major Depression: Some Philosophical Problems in Everyday Clinical Practice. Philosophy, psychiatry & psychology. https://doi.org/10.1353/ppp.2017.0028
427. Liexi, L. (2008). Psychosocial Factors in Functional Dyspepsia. Weichangbingxue.
428. Lilienfeld, S. O., & Latzman, R. D. (2018). Personality disorders: Current scientific status and ongoing controversies.. American Psychological Association eBooks. https://doi.org/10.1037/0000064-023
429. Linares, E. J. (2002). Los juicios de control sobre los agentes de salud: variable moduladora de la calidad de vida de los enfermos de cáncer de pulmón avanzado sometidos a tratamiento paliativo. TDX (Tesis Doctorals en Xarxa).
430. Linden, M. (2020). Euthymic suffering and wisdom psychology. World Psychiatry. https://doi.org/10.1002/wps.20718
431. Ling, C. Y., Klainin, P., & Ignacio, J. (2009). The impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review. The JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/01938924-200907241-00010
432. Lipsitz, L. A. (2004). Physiological Complexity, Aging, and the Path to Frailty. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2004.16.pe16
433. Liu, S. (2011). Relationship Discussion between Emotional Factors and Chronic Fatigue Syndrome. Liaoning Zhongyiyao Daxue xuebao.
434. Lloyd, G. (2007). Understanding psychological reactions to physical illness. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543975.005
435. Lockhart, S., Sawa, A., & Niwa, M. (2018). Developmental trajectories of brain maturation and behavior: Relevance to major mental illnesses. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2018.04.008
436. Londoño, F. U., Franco, J. G., Franco, L. F. M., & Tobón, L. A. L. (2005). Ejes neuroendocrinos del estrés, síndrome metabólico y alteraciones psiquiátricas del síndrome de Cushing. IATREIA. https://doi.org/10.17533/udea.iatreia.4249
437. Long, M. C. (2018). Headache: Posttraumatic Headache.. PubMed.
438. Lopresti, A. L., & Drummond, P. D. (2019). Lifestyle and neuroprogression: Diet, sleep, and exercise. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198787143.003.0013
439. Losada‐Baltar, A., Chaparro, M. D. S. P., Gallego‐Alberto, L., Huertas, C., & González, M. M. (2020). Sentimientos de ambivalencia y culpa en cuidadores familiares de personas con demencia: Aspectos teóricos y prácticos. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
440. Louis, E. D. (2013). ‘Essential Tremor' or ‘the Essential Tremors': Is This One Disease or a Family of Diseases?. Neuroepidemiology. https://doi.org/10.1159/000356351
441. Lundberg, A. (1996). Psychiatric aspects of air pollution. Otolaryngology. https://doi.org/10.1016/s0194-5998(96)70172-9
442. Lundberg, A. (1996). Psychiatric Aspects of Air Pollution. Otolaryngology. https://doi.org/10.1016/s0194-59989670172-9
443. Lundh, L. (1987). Placebo, belief, and health. A cognitive–emotion model. Scandinavian Journal of Psychology. https://doi.org/10.1111/j.1467-9450.1987.tb00747.x
444. Luz, K. P. D. S., & Coronago, V. M. M. O. (2017). A Doença de Parkinson na pessoa Idosa e a Relação com sua Qualidade de Vida. ID on line REVISTA DE PSICOLOGIA. https://doi.org/10.14295/idonline.v11i35.720
445. Löffler‐Stastka, H., & Steinmair, D. (2009). Psychoanalytical Theory of Affects and Its Applicability on the Affect Regulation and Affect Experience Q-Sort Test (AREQ). Journal of Medical Psychology.
446. MacGilvray, P., Williams, R., & Dambro, A. (2016). Anxiety Disorders. Family Medicine. https://doi.org/10.1007/978-3-319-04414-9_32
447. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
448. MacPherson, H. A. (2019). More than medication: The importance of family treatments for pediatric bipolar disorder. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30433
449. Madakasira, S. (2022). Psychodynamic factors in psychotropic prescribing. Current psychiatry. https://doi.org/10.12788/cp.0245
450. Madhavi, A., & Savitha, H. P. (2017). Depression- An Ayurvedic Outlook. Journal of Ayurveda and Holistic Medicine.
451. Mafi, M. (2020). 4th International Conference onPsychiatry and PsychologicalDisorders. Deleted Journal.
452. Mahato, A. N., Mudaliyar, S., & Azad, S. C. (2024). Pseudobulbar affect masquerading as psychosis: Managing a case of diagnostic dilemma. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_117_24
453. Mahmood, A., & Ebmeier, K. P. (2015). Optimising the management of bipolar disorder.. PubMed.
454. Mahmoud, O., Azab, H., Mohammed, Y., & Sayed, T. A. (2022). Early intervention for challenging behaviour in intellectual disability. Sohag Medical Journal. https://doi.org/10.21608/smj.2022.159565.1342
455. Maletic, V., & DeMuri, B. (2016). Chronic Pain and Depression: Understanding 2 Culprits in Common: Does a Shared Pathophysiology Hold the Key to Managing These Conditions When They Coexist?. Current psychiatry.
456. Malt, E. A., & Sundet, K. (2002). [Whiplash injuries--a psychosomatic perspective].. PubMed.
457. Malt, U. F., Malt, E. A., Blomhoff, S., & Refnin, I. (2002). [Functional somatic diseases--a review].. PubMed.
458. Malterud, K., & Aamland, A. (2019). Medically unexplained symptoms: are we making progress?. British Journal of General Practice. https://doi.org/10.3399/bjgp19x701885
459. Manohar, S., Koolwal, A., & Rao, T. S. (2019). Sex and Depression. Journal of Psychosexual Health. https://doi.org/10.1177/2631831818821532
460. Manohar, S., Rao, T. S., Chandran, S., Maheshwari, S., George, M., Rao, S. S., & Sattar, F. A. (2017). Sexual Dysfunctions in Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000125
461. Marks, R. (2018). Exercise Psychology Considerations for Chronically Ill Patients. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.221
462. Marriott, R. A. (2018). Relationship between physical illness and affective disorders. CRC Press eBooks. https://doi.org/10.1201/9781315382913-9
463. Martins-Monteverde, C. M. S., Padovan, T., & Juruena, M. F. (2017). Trauma and stressor-related disorders. Medicina (Ribeirão Preto). https://doi.org/10.11606/issn.2176-7262.v50isupl1.p37-50
464. Martínez‐Castrillo, J. C., Vela, L., Val, J. D., & Alonso‐Cánovas, A. (2011). Nonmotor Disorders and Their Correlation With Dopamine. The Neurologist. https://doi.org/10.1097/nrl.0b013e318239669f
465. Mary, P. K., Sreejith, K. R., Arya, S., Thamanna, V. K., Salim, M., & Maziya, S. (2021). A REVIEW ON IMPACT OF PSYCHOLOGICAL STRESS IN IMMUNE RESPONSES IN DIFFERENT PATHOLOGICAL AND PHYSIOLOGICAL CONDITIONS.
466. María, A., Sancho, R., & Pita, B. L. (2005). Trastornos de ansiedad en la infancia y en la adolescencia.
467. Masgutova, S., Wenberg, S., & Retschler, M. (2008). MASGUTOVA METHOD OF REFLEX INTEGRATION FOR CHILDREN WITH CEREBRAL PALSY.
468. Masoodi, S. A., & Maqbool, P. S. (2017). Posttraumatic Growth through Quran and Sunna: Islamic Perspective. International Journal of Indian Psychology. https://doi.org/10.25215/0402.065
469. Matisz, C. E., & Gruber, A. J. (2020). Neuroinflammatory Remodeling of the Anterior Cingulate Cortex as a Key Driver of Mood Disorders in Gastrointestinal Disease and Disorders. https://doi.org/10.20944/preprints202009.0593.v1
470. Mayberg, H. S., & Lozano, A. M. (2002). Penfield revisited?. Neurology. https://doi.org/10.1212/wnl.59.9.1298
471. Mazumdar, H., Haloi, N., & Mazumdar, M. (2011). Impact of job stress on urban and rural employees in Kamrup district, Assam (India): A physiological and psychological study.. Archives of applied science research.
472. Mc, M.-S. (1993). [Post-traumatic stress syndrome in children].. PubMed.
473. McBain, H., Cleanthous, S., & Newman, S. (2013). Psychology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199642489.003.0026
474. McCoy, D. (1996). Treatment considerations for depression in patients with significant medical comorbidity.. PubMed.
475. McElroy, S. L. (2004). Bipolar Disorders: Special Diagnostic and Treatment Considerations in Women. CNS Spectrums. https://doi.org/10.1017/s1092852900002327
476. McEwen, B. S. (2020). Basic mechanisms of, and treatment targets for, stress-related disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0079
477. McGorry, P. D., & Yung, A. R. (2020). Transition to adulthood. Routledge eBooks. https://doi.org/10.4324/9780429285806-2
478. McKinnon, M. C., Cusi, A. M., & MacQueen, G. (2012). Psychological factors that may confer risk for bipolar disorder. Cognitive Neuropsychiatry. https://doi.org/10.1080/13546805.2012.702505
479. McLeod, T. C. V., & Register‐Mihalik, J. K. (2011). Clinical Outcomes Assessment for the Management of Sport-Related Concussion. Journal of Sport Rehabilitation. https://doi.org/10.1123/jsr.20.1.46
480. McMurran, M. (2012). Other Personality Disorders. https://doi.org/10.1002/9781118156391.ebcp002023
481. McQuillan, R. (2020). Symptoms other than pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0065
482. McReynolds, C. J., Koch, L. C., & Rumrill, P. D. (1999). Psychosocial adjustment to multiple sclerosis: implications for rehabilitation professionals. Journal of Vocational Rehabilitation. https://doi.org/10.3233/jvr-1999-00014
483. Mechlińska, A., Wiglusz, M. S., Słupski, J., Włodarczyk, A., & Cubała, W. J. (2023). Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals. Brain Sciences. https://doi.org/10.3390/brainsci13091262
484. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
485. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
486. Mehta, P., & Rani, G. S. (2020). Identification and Early Intervention of Bipolar Disorder in Adolescence and Adults. International Journal of Engineering and Advanced Technology. https://doi.org/10.35940/ijeat.b3637.029320
487. Mehta, U. M., & Chaturvedi, S. K. (2022). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198861478.003.0044
488. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo Obesity and mental disorders: building an effective care.
489. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo. Revista Hospital Universitário Pedro Ernesto. https://doi.org/10.12957/rhupe.2014.9794
490. Menefee, D. S., Ledoux, T., & Johnston, C. A. (2022). The Importance of Emotional Regulation in Mental Health. American Journal of Lifestyle Medicine. https://doi.org/10.1177/15598276211049771
491. Menezes, A. R., Lavie, C. J., Milani, R. V., O’Keefe, J. H., & Lavie, T. J. (2011). Psychological Risk Factors and Cardiovascular Disease: Is it All in Your Head?. Postgraduate Medicine. https://doi.org/10.3810/pgm.2011.09.2472
492. Mercer, S. W., Gunn, J., Bower, P., Wyke, S., & Guthrie, B. (2012). Managing patients with mental and physical multimorbidity. BMJ. https://doi.org/10.1136/bmj.e5559
493. Meyer, J. S., & Hamel, A. F. (2014). Models of Stress in Nonhuman Primates and Their Relevance for Human Psychopathology and Endocrine Dysfunction. ILAR Journal. https://doi.org/10.1093/ilar/ilu023
494. Mialet, J.-P. (2003). [From back pain to life-discontent. A holistic view of psychopathological contributions to pain].. PubMed.
495. Michel, G., & Kurth, T. (2014). Stressful headache already among young adults?. Cephalalgia. https://doi.org/10.1177/0333102414562973
496. Michel, J., Gisselbaek, A., Gauthey, L., & Zelger, G. L. (1993). [Non-compliant drug taking in elderly subjects].. PubMed.
497. Michie, S. (2002). CAUSES AND MANAGEMENT OF STRESS AT WORK. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.1.67
498. Micoulaud‐Franchi, J., Lemogne, C., & Quilès, C. (2019). [Definition of somatoform disorders: somatic symptoms or mental symptoms?]. PubMed.
499. Mihanović, M., Bodor, D., Kezić, S., Restek-Petrović, B., & Silić, A. (2009). Differential diagnosis of psychotropic side effects and symptoms and signs of psychiatric disorders.. PubMed.
500. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
501. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
502. Miklowitz, D. J., & Johnson, S. L. (2009). Social and familial factors in the course of bipolar disorder: Basic processes and relevant interventions.. Clinical Psychology Science and Practice. https://doi.org/10.1111/j.1468-2850.2009.01166.x
503. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
504. Milosavljević, M., & Vuković, O. (2020). Mental disorders in the peripartum period. Psihijatrija danas. https://doi.org/10.5937/psihdan2001131m
505. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
506. Mitchell, P. B., Goodwin, G. M., Johnson, G. F., & Hirschfeld, R. M. A. (2008). Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00559.x
507. Mittermaier, C., Niederkrotenthaler, E., Raschhofer, R., Röper, C., & Kisling, R. (2018). Haben depressive Symptome Einfluss auf die Therapieteilnahme älterer PatientInnen auf einer Akutgeriatrie?. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. https://doi.org/10.1055/s-0038-1625800
508. Miyoshi, K. (2001). Depression Associated with Physical Illness.
509. MM, B., Islam, S., Nh, S., Rahman, M., & Bari, M. (2016). None. MOJ Orthopedics & Rheumatology. https://doi.org/10.15406/mojor.4.1
510. Molière, F. (2014). Comorbidités psychiatriques et résistance thérapeutique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.052
511. Mollenhauer, B., & Weintraub, D. (2017). The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700737114
512. Montejo, Á. L., Montejo, L., & Baldwin, D. S. (2018). The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. https://doi.org/10.1002/wps.20509
513. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
514. Montoya, A., & Alejandra, M. (2020). Estrés laboral y sus consecuencias en la salud que afectan el rendimiento.
515. Moreno, M. R., Biswas, S., Harrison, L. D., Pernelle, G., Miller, M. W., Fossum, T. W., Nelson, D. A., & Criscione, J. C. (2011). Assessment of Minimally Invasive Device That Provides Simultaneous Adjustable Cardiac Support and Active Synchronous Assist in an Acute Heart Failure Model. ASME 2008 Summer Bioengineering Conference, Parts A and B. https://doi.org/10.1115/sbc2011-53089
516. Moreno‐Fernández, R. D., Tabbai, S., Castilla‐Ortega, E., Pérez‐Martín, M., Estivill‐Torrús, G., Fernando, R. D. F., Santín, L. J., & Pedraza, C. (2017). Stress, Depression, Resilience and Ageing: A Role for the LPA-LPA1 Pathway. Current Neuropharmacology. https://doi.org/10.2174/1570159x15666170710200352
517. Moretti, R., Torre, P., Antonello, R. M., & Pizzolato, G. (2006). Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer’s disease: risks or benefits. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.5.705
518. Morin, C. (2009). [Sense of personal identity and focal brain lesions].. PubMed. https://doi.org/10.1684/pnv.2009.0156
519. Morris, R. C. (2020). Psychological and emotional issues after stroke. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198747499.003.0026
520. Moser, G. (2007). [Psychotherapy in somatic diseases--for example gastrointestinal disorders].. Psychiatria Danubina.
521. Moukaddam, N., & Shah, A. A. (2016). Treatment-Resistant Depression: An Overview. Psychiatric Annals. https://doi.org/10.3928/00485713-20160215-01
522. Moyo⃰, G. P. K. (2020). Perinatality and Childbirth as a Factor of Decompensation of Mental Illness: The Case of Depressive States in Newly Delivered Cameroonian Women. Archives in Biomedical Engineering & Biotechnology. https://doi.org/10.33552/abeb.2020.04.000592
523. Mundy, R. R., Moore, S. C., Corey, J. B., & Mundy, G. D. (1994). Disability Syndrome. Workplace Health & Safety. https://doi.org/10.1177/216507999404200806
524. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
525. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
526. Munteanu, D., Vlase, A., Perţea, L., Felea, M. G., Rusu, A., Ciorap, R., & Anton-Prisacariu, B. (2022). Neuropsychic pathology in the context of anterior chest pain. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2022.3.06
527. Murcia, S. V. N. (2016). La bebida compulsiva en polidipsia inducida por programa como rasgo de vulnerabilidad psicopatológica en ratas: implicaciones de la serotonina en su desarrollo y mantenimiento.
528. Müller‐Spahn, F., & Hock, C. (1994). Clinical Presentation of Depression in the Elderly. Gerontology. https://doi.org/10.1159/000213615
529. Münster, T., & Tzabazis, A. (2013). Somatische Intervention und Demenz - Einfluss von Chirurgie und Anästhesie auf kognitive Funktionen. PSYCH up2date. https://doi.org/10.1055/s-0033-1343131
530. Nader, K., & Williams, M. B. (2018). Trauma- and Stressor-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780190634841.013.22
531. Naidoo, S. (2015). Managing stress in the dental environment.
532. Naik, D. (2016). Role of Behavioural Techniques in Patients with Insomnia and Headache. Indian Journal of Health and Wellbeing.
533. Nandi, K., Sarkar, S., Bakshi, P., Chandra, A. C., Chakraborty, A., Mondal, S., Biswas, A., Bera, K., Sen, D. J., & Saha, D. (2005). COVID-19 & CO-MORBIDITY: DEMONIC FORCES THAT SUPRESS THE CIVILIZATION. World Journal of Pharmaceutical and life sciences.
534. Narang, T., Garima, & Singh, S. M. (2016). Psychosexual disorders and dermatologists. Indian Dermatology Online Journal. https://doi.org/10.4103/2229-5178.182349
535. Nash, S., Hutner, L. A., & Caligor, E. (2014). Psychological Factors Affecting Medical Conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0011
536. Nasrallah, H. A. (2005). Avoiding Side Effects in Ethnically Diverse Patients. CNS Spectrums. https://doi.org/10.1017/s1092852900026572
537. Nasrallah, H. A. (2009). Diagnosis 2.0 Are Mental Illnesses Diseases, Disorders, or Syndromes? A Major Challenge for the DSM-V Committees as They Revise the Diagnostic "Bible" of Psychiatric Disorders Is to Determine Whether Mental Illnesses Are Diseases, Disorders, or Syndromes. Current psychiatry.
538. Nasrallah, H. A. (2014). Borderline Personality Disorder Is a Heritable Brain Disease. Current psychiatry.
539. Navarro, P. V., López, D. L., & Cárdenas, S. P. (2015). Estresores psicosociales y depresión mayor recurrente. Revista Salud Bosque. https://doi.org/10.18270/rsb.v1i2.94
540. Negomireanu, A.-S. B., & Delcea, C. (2022). Sexual dysfunction, mental illness and quality of life: a systematic review of the literature. International Journal of Advanced Studies in Sexology. https://doi.org/10.46388/ijass.2022.4.12
541. Neves, T. B., Ponte, G. D., & Lobo, M. (2011). Psychiatrist's reactions to patient suicide. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)73315-6
542. Ng, J.-S., & Chin, K. (2020). Potential mechanisms linking psychological stress to bone health. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.50680
543. Nicholson, T. R., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., Mildon, B., Nielsen, G., Nicholson, C., Perez, D. L., Pick, S., Stone, J., Anderson, D. G., Asadi‐Pooya, A. A., Aybek, S., Baslet, G., Bloem, B., Brown, R. J., Chalder, T., Damianova, M., ... Tinazzi, M. (2019). Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.19060128
544. Nikiphorou, E., Radner, H., Chatzidionysiou, K., Desthieux, C., Zăbălan, C., Eijk‐Hustings, Y. V., Dixon, W. G., Hyrich, K. L., Askling, J., & Gossec, L. (2016). Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature. Arthritis Research & Therapy. https://doi.org/10.1186/s13075-016-1151-6
545. Nuralieva, N., & Federation, R. (2014). Депрессия и сердечно-сосудистые заболевания.
546. Nutt, D. (2001). The Pharmacology of Human Anxiety. https://doi.org/10.1002/0470846437.ch16
547. Oers, H. M. V. (2019). Correlates of psychiatric and psychological distress in patients with Parkinson’s disease. https://doi.org/10.36811/jphsm.2019.110010
548. Oishe, O. F., Islam, S., Pakrad, P., Chikatimalla, R., & Jain, R. (2025). Mental Health Sequelae of Cardiac Events: A Comprehensive Review of Biological Mechanisms, Prevalence, and Interdisciplinary Care Approaches. Cardiology in Review. https://doi.org/10.1097/crd.0000000000000924
549. Ojeda, B. S., Salazar, A., Dueñas, W. A. M., & Failde, I. (2011). El deterioro cognitivo: un factor a tener en cuenta en la evaluación e intervención de pacientes con dolor crónico. Revista de la Sociedad Española del Dolor.
550. Oken, B. (2000). A Systems Approach to Stress and Resilience in Humans: Mindfulness Meditation, Aging, and Cognitive Function. https://doi.org/10.15760/etd.2696
551. Oken, B. (2003). Non-prescription and non-pharmacological therapies for dementia. CRC Press eBooks. https://doi.org/10.3109/9780203494578-29
552. Okuniewska, A., Walczuk, B. I., Czubek, M., & Biernat, W. (2011). Recurrent Deep Ulcers Resembling Rare Cancers as a Form of Factitious Disorder. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-1027
553. Oleshko, O., Berladir, K., Oleshko, T., Hlushchenko, V., Korol, O., Bilokonskyi, V., Boiko, V., Kiriienko, O., Chaikin, R., & Larin, O. (2025). NEUROBIOLOGICAL ASPECTS OF PATHOGENETIC MECHANISMS IN THE DEVELOPMENT OF POST-TRAUMATIC STRESS DISORDER (LITERATURE REVIEW). Eastern Ukrainian Medical Journal. https://doi.org/10.21272/eumj.2025;13(1):39-54
554. Oliveira, C. C. D., & Feitosa, C. R. H. F. (2008). Imagens no espelho de vênus: vivências inconscientes. ID on line REVISTA DE PSICOLOGIA. https://doi.org/10.14295/idonline.v2i4.159
555. Oliveira, E. R., Aquino, N. K. D. M., & Varela, D. S. D. S. (2019). RELATO DE EXPERIÊNCIA DE UM PACIENTE COM DIAGNÓSTICO DE SINDROME DE PUSHER.
556. Oruç, G. A., & Gültekin, B. K. (2018). The critical period in patients with psychosis: "Duration of Untreated Psychosis" and social determinants. Journal of Clinical Psychiatry. https://doi.org/10.5505/kpd.2018.38258
557. Oughli, H. A. (2022). Resilience and mind-body interventions in late-life depression. Current psychiatry. https://doi.org/10.12788/cp.0308
558. Ownsworth, T., & Oei, T. P. S. (1999). Depresión después de una lesión traumática del cerebro: consideraciones sobre el concepto y el tratamiento. RET: revista de toxicomanías.
559. O’Dwyer, A.-M., & Campion, M. (2022). Anxiety and obsessional disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198867135.003.0008
560. O’Keeffe, M., George, S. Z., O’Sullivan, P., & O’Sullivan, K. (2018). Psychosocial factors in low back pain: letting go of our misconceptions can help management. British Journal of Sports Medicine. https://doi.org/10.1136/bjsports-2018-099816
561. O’Shea, B. (2001). Post-traumatic stress disorder: A review for the general psychiatrist. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/136515001300225141
562. Pais, S. C., Menezes, I., & Nunes, J. A. (2016). From Normative to Deviant Behaviour: Health and Illness Definitions Related to Children and Adolescents’ Perspectives. BRILL eBooks. https://doi.org/10.1163/9781848884885_004
563. Pal, K., Kundu, S. K., Bhattacharjee, S., & Roy, S. (2014). A Review Paper on Psychiatry Disorders & its Treatment by Ayurvedic Approach. Pharmatutor.
564. Panza, F., Frisardi, V., Capurso, C., D’Introno, A., Colacicco, A. M., Seripa, D., Pilotto, A., Vendemiale, G., Capurso, A., & Solfrizzi, V. (2009). POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2009.02236.x
565. Paparrigopoulos, T., Ferentinos, P., Kouzoupis, A. B., Koutsis, G., & Papadimitriou, G. N. (2010). The neuropsychiatry of multiple sclerosis: Focus on disorders of mood, affect and behaviour. International Review of Psychiatry. https://doi.org/10.3109/09540261003589323
566. Parada, S. M. (2018). Mecanismos neurobiológicos e inmunes que subyacen al déficit en control inhibitorio: estudios preclínicos.
567. Pardo, J. M. V., & García, A. L.-G. (2018). Los factores psicosociales como predictores pronósticos de difícil retorno laboral tras incapacidad. DOAJ (DOAJ: Directory of Open Access Journals).
568. Parkinson, J. T., Foley, É. M., Jadon, D. R., & Khandaker, G. M. (2020). Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720x20970028
569. Parra, M. D. S. (2012). Resiliencia y salud mental en mayores. Validación de la escala de resiliencia cd-risc.
570. Paruk, S., & Karim, E. (2016). Update on adolescent mental health. South African Medical Journal. https://doi.org/10.7196/samj.2016.v106i6.10943
571. Pascual, J. C. (2003). Impulsividad y conducta: bases psicobiológicas y tratamientos farmacológicos. European psychiatry (Ed Española). https://doi.org/10.1017/s1134066500007104
572. Pascual‐Leone, Á., Ramachandran, V. S., Cole, J., Sala, S. D., Manly, T., Mayes, A. R., & Sacks, O. (2011). The Paradoxical Brain. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511978098
573. patil, A. J. (2017). Role of satvavajaya chikitsa in jara with special reference to socio-psychological problems. Journal of Ayurveda and Holistic Medicine.
574. Patricia, G. C. C., AAngela, G.-M., & Marina, R.-A. (2017). Diagnostic and therapeutical challenges of late-onset psychosis.. Journal of Psychology and Cognition. https://doi.org/10.35841/psychology-cognition.2.4.218-220
575. Pavlichenko, A. (2018). Negative symptoms of schizophrenia: the conceptualization and pathophysiological mechanisms. Part 1. Psikhiatriya. https://doi.org/10.30629/2618-6667-2018-77-86-96
576. Peluso, M. A. M., & Andrade, L. H. (2005). PHYSICAL ACTIVITY AND MENTAL HEALTH: THE ASSOCIATION BETWEEN EXERCISE AND MOOD. Clinics. https://doi.org/10.1590/s1807-59322005000100012
577. Penlington, C., Urbanek, M., & Barker, S. (2018). Psychological Theories of Pain. Primary Dental Journal. https://doi.org/10.1177/205016841800700407
578. Penninx, B. W., & Dyck, R. V. (2001). Depression and Somatic Comorbidity. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1080/0004867010060522
579. Pereira, A. F. O. A. (2010). Percepción de las características sociales de las manifestaciones afectivo-emocionales de sí mismo, en el paciente oncológico.
580. Pereira, R., Martins, S., & Fernandes, L. (2017). Review of Association Between Delirium and Dementia in Elderly People. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.1107
581. Peretti, C.-S., Ferreri, F., & Crucis, B. (2009). Troubles cognitifs dans la dépression. La Lettre du psychiatre.
582. Pestana‐Santos, A., Ribeiro, J. S., & Teixeira, J. (2015). The Missing 'p' in Chronic Pain Management. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)30260-1
583. Petruševičienė, D., & Kriščiūnas, A. (2003). [Occupational therapy for patients after stroke].. PubMed.
584. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
585. Peñas‐Lledó, E., Dorado, P., & LLerena, A. (2010). Pharmacogenomics and Personality: Role of CYP2D6 and Implications for Psychopathology. Advances in biological psychiatry. https://doi.org/10.1159/000317297
586. Phan, S. (2013). Primary or secondary? What came first and how to treat?. Mental Health Clinician. https://doi.org/10.9740/mhc.n178411
587. Phan, S. V. (2016). Medication adherence in patients with schizophrenia. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217416636601
588. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
589. Pietzcker, A. (1996). [Medical expert assessment in psychiatry].. PubMed.
590. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
591. Pinderhughes, C., & Pearlman, C. (1969). Psychiatric Aspects of Idiopathic Cardiomyopathy. Psychosomatic Medicine. https://doi.org/10.1097/00006842-196901000-00006
592. Pivac, N., Perković, M. N., Erjavec, G. N., Dodig‐Ćurković, K., Ćurković, M., Škledar, M., & Mück‐Šeler, D. (2010). Molecular markers of behavioral and emotional disorders.
593. Pizov, A. V. (2022). Peculiarities of insomnia in men and women at different age periods. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2022-16-21-112-118
594. Plotkin, K. E. (2004). Insomnia Caused by Medical and Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-662-1_10
595. Poewe, W., & Luginger, E. (1999). Depression in Parkinson's disease: impediments to recognition and treatment options.. PubMed.
596. Porcelli, P., Laera, D., Mastrangelo, D., & Masi, A. D. (2012). Prevalence of Allostatic Overload Syndrome in Patients with Chronic Cardiovascular Disease. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000341179
597. Post, R. M. (2018). Depression as a Recurrent, Progressive Illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190603342.003.0003
598. Postma, A., Nelson, C. M., Dijk, J. V., & Dijk, R. V. (2010). Deaf Children with Severe Multiple Disabilities:. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195390032.013.0012
599. Presečki, P., Filipčić, I., Arbanas, G., & Mimica, N. (2014). Neurocognitive disorders in DSM-5.
600. Profenno, L. A., & Tariot, P. N. (2003). Pharmacologic Management of Agitation in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000074278
601. Provini, F., Vetrugno, R., & Montagna, P. (2008). Restless legs syndrome: effects on cognitive functioning, memory, and psychomotor performance. CRC Press eBooks. https://doi.org/10.3109/9780203091715-54
602. Puigcerver, A., & Arenas, M. C. (2009). Diferencias entre hombres y mujeres en los trastornos de ansiedad: una aproximación psicobiológica. Escritos de Psicología / Psychological Writings. https://doi.org/10.24310/espsiescpsi.v3i1.13331
603. Puri, B. K., & Treasaden, I. H. (2008). Chapter 17 Emergencies in old-age psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198530800.003.0017
604. Putranto, R., Shatri, H., Wijaya, I. P., & Faisal, E. (2021). Depresi pada Gagal Jantung: Pendekatan Psikosomatik. Jurnal Penyakit Dalam Indonesia. https://doi.org/10.7454/jpdi.v8i3.182
605. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
606. Quaderi, A., Tafazzoli, S., Miloni, A., & Palazzolo, J. (2017). Depressive disorders: A multidimensional non-drug approach. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.736
607. Qualls, S. H. (2002). Defining Mental Health in Later Life. Generations.
608. Quintero, J. M. B., Castellanos, A., & Santos, L. S. D. L. (2018). Efectividad de una intervención pre-quirúrgica de enfermería; en ansiedad de pacientes sometidos a colecistectomía del Hospital General Regional No.1 Vicente Guerrero de Acapulco, 2017.
609. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
610. Racciatti, D., Barberio, A., Vecchiet, J., & Pizzigallo, E. (1999). Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v05n03_05
611. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve Mild cognitive impairment.
612. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v94i3p162-168
613. Radi, F. (2008). Employment as one of ways of integrating handicapped citizens. Kontakt. https://doi.org/10.32725/kont.2008.014
614. Rakofsky, J. J., & Dunlop, B. W. (2014). Treating Bipolar Mania in the Outpatient Setting: Enlist the Help of Family, Employ Evidence-Based Pharmacologic and Psychotherapeutic Strategies. Current psychiatry.
615. Ramig, L. O., & Verdolini, K. (1998). Treatment Efficacy. Journal of Speech Language and Hearing Research. https://doi.org/10.1044/jslhr.4101.s101
616. Ravi, M., Miller, A. H., & Michopoulos, V. (2021). The immunology of stress and the impact of inflammation on the brain and behaviour. BJPsych Advances. https://doi.org/10.1192/bja.2020.82
617. Ray, C., Jeffefues, S., Weir, W., Hayes, K., Simon, S., Akingbade, F., & Marriott, P. (1998). Making sense of chronic fatigue syndrome: Patients' accounts of onset. Psychology and Health. https://doi.org/10.1080/08870449808406134
618. Rayfield, A., Thomas, C., & Borovicka, M. C. (2014). Management of behavioral and psychological symptoms of dementia: The role of mood stabilizers. Mental Health Clinician. https://doi.org/10.9740/mhc.n204493
619. Rd, G. (1996). Behavioral factors in the management of back pain.. PubMed.
620. Rebolleda, J. G. (2013). Estudio de los síntomas somáticos asociados a los trastornos depresivos y de ansiedad en una población de atención primaria.
621. Reddy, S., Elsayem, A., & Talukdar, R. (2005). Palliative Care. CRC Press eBooks. https://doi.org/10.1201/b14119-59
622. Reid, W. H. (2018). Psychological Factors Affecting Physical Condition. Routledge eBooks. https://doi.org/10.4324/9781315825908-30
623. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
624. Reuber, M., Schachter, S. C., Elger, C. E., & Altrup, U. (2009). Conditions Associated With Epilepsy. https://doi.org/10.1093/oso/9780195379532.003.0005
625. Revicki, D. A. (2005). Methodological issues and the measurement of fatigue in primary biliary cirrhosis. Hepatology. https://doi.org/10.1002/hep.20789
626. Revuelta, E. B., & Rioja, E. M. (2018). Síntomas psicológicos y conductuales de las demencias. El papel de las terapias no farmacológicas. Revisión bibliográfica. Nuberos Científica.
627. Rey, J. M. (1996). Antecedents of Personality Disorders in Young Adults.
628. Reynolds, C. F., Alexopoulos, G. S., & Katz, I. R. (2002). Geriatric Depression: Diagnosis and Treatment. Generations.
629. Reynolds, C. F., Areán, P. A., Lynch, T. R., & Frank, E. (2004). Psychotherapy in old-age depression: Progress and challenges. https://doi.org/10.1093/oso/9780195152746.003.0023
630. Rhenen, W. V., Roelen, C. A. M., Koopmans, P. C., Bültmann, U., Groothoff, J. W., & Klink, J. J. L. V. D. (2012). Sickness absence due to mental health disorders--a societal perspective. Occupational Medicine. https://doi.org/10.1093/occmed/kqs065
631. Ricciardelli, R., & Johnston, M. S. (2022). Police Mental Health and Wellness. Oxford Research Encyclopedia of Criminology and Criminal Justice. https://doi.org/10.1093/acrefore/9780190264079.013.752
632. RIED, L. M. (2018). RELAÇÃO ENTRE A DEPRESSÃO E A DEMÊNCIA DO TIPO ALZHEIMER. https://doi.org/10.17771/pucrio.acad.36288
633. Righter, E. L., & Sansone, R. A. (1999). Managing somatic preoccupation.. PubMed.
634. Rihmer, Z., Gonda, X., Rihmer, A., & Döme, P. (2016). [Antidepressant-resistant depression and the bipolar spectrum -- diagnostic and therapeutic considerations].. PubMed.
635. Rizzo, M. (2011). Impaired Driving From Medical Conditions. JAMA. https://doi.org/10.1001/jama.2011.252
636. Rm, T., Seth, P., Awasthi, P., Bhattacharya, A., Ak, B., & Thahriani, A. (2018). Psychosomatic disorders affecting the oral cavity: A review article. Deleted Journal.
637. Rnic, K., & Dozois, D. J. A. (2020). Depression. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch197
638. Robinson, R. G. (1997). NEUROPSYCHIATRIC CONSEQUENCES OF STROKE. Annual Review of Medicine. https://doi.org/10.1146/annurev.med.48.1.217
639. Rodrigues, F. D. A. A. (2022). WHAT HAPPENS IN THE BRAIN OF A PERSON WITH DISORDER. International Journal of Health Science. https://doi.org/10.22533/at.ed.1592442202087
640. Rodríguez, J. R., Quiñones-Maldonado, R., & Alvarado-Pomales, A. (2010). Military suicide: factors that need to be taken into consideration to understand the phenomena.. PubMed.
641. Rodríguez, M. J. M., Barceló, J. S., Millares, M. V., Alfonso, A. P., Guzmán, P. D. U., Barbazán, C. A., & Mahía, M. D. C. G. (2013). Es la edad de inicio del trastorno bipolar un buen marcador de dos entidades distintas. Revista gallega de psiquiatría y neurociencias.
642. Roepke, S., Vater, A., Preißler, S., Heekeren, H. R., & Dziobek, I. (2013). Social cognition in borderline personality disorder. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2012.00195
643. Rogol, A. M. (2020). Ethical Issues in the Evaluation and Treatment of Depression. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20200006
644. Rosa, A. R., & Lima, F. M. (2019). Functioning and illness progression in severe mental illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198787143.003.0009
645. Roshannia, S., Rezaei, F., & Ghadampoor, E. (2017). An Overview of Psychological Factors in Epilepsy. The Neuroscience Journal of Shefaye Khatam. https://doi.org/10.18869/acadpub.shefa.5.2.110
646. Rosli, A. (2017). Antidepressant Activity of Spirulina Platensis in Models of Depression. Psychology and Mental Health Care. https://doi.org/10.31579/2637-8892/003
647. Rossettini, G., Carlino, E., & Testa, M. (2018). Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeletal pain. BMC Musculoskeletal Disorders. https://doi.org/10.1186/s12891-018-1943-8
648. Rotaru, L., Grosu, O., & Groppa, S. (2023). Current level of knowledge about Parkinson’s disease cognitive impairment: review. The Moldovan Medical Journal. https://doi.org/10.52418/moldovan-med-j.66-2.23.15
649. Rothärmel, M., Quesada, P., Compère, V., & Guilllin, O. (2017). Repeated Transcranial Magnetic Stimulation (rTMS) to improve Electroconvulsive Therapy (ECT) in Treatment-Resistant Depression: A Report of Two Cases. Journal of Depression & Anxiety. https://doi.org/10.4172/2167-1044.s12-005
650. Rovai, D., Giannessi, D., Andreassi, M. G., Gentili, C., Pingitore, A., Glauber, M., & Gemignani, A. (2014). Mind injuries after cardiac surgery. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0000000000000133
651. Rowe, J. B. (2010). Conversion disorder: understanding the pathogenic links between emotion and motor systems in the brain. Brain. https://doi.org/10.1093/brain/awq096
652. Rowland, D. L., & Incrocci, L. (2008). Appendix: Alphabetical Listing of DSM‐IV Sexual and Gender Identity Disorders Reviewed. https://doi.org/10.1002/9781118269978.app1
653. Rozenberg, S. (2008). [Chronic low back pain: definition and treatment].. PubMed.
654. Rubin, D. C., Berntsen, D., & Bohni, M. K. (2008). A memory-based model of posttraumatic stress disorder: Evaluating basic assumptions underlying the PTSD diagnosis.. Psychological Review. https://doi.org/10.1037/a0013397
655. Rumble, M. E., & Benca, R. M. (2016). Clinical Assessment of Comorbid Insomnias: Insomnia in Psychiatric Disorders. https://doi.org/10.3109/9781420080803-15
656. Russello, A. (2018). Understanding mental health and mental illness. CRC Press eBooks. https://doi.org/10.4324/9781315383231-3
657. Rzeszut, M., & Assael, R. (2020). Differentiating Depression From Demoralization in Organ Transplantation Recipients. Progress in Transplantation. https://doi.org/10.1177/1526924820978602
658. Saaresranta, T., Polo‐Kantola, P., & Polo, O. (2013). Practical Approach for the Diagnosis and Management of Insomnia During Menopausal Transition. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-324-4_19
659. Saba, G. (2014). Comorbidités somatiques et résistance thérapeutique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.053
660. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
661. Sahoo, S., Panigrahi, H., Rao, B. N. B., & Sudhakar, D. (2013). PSYCHOLOGICAL PROBLEMS OF THE AGED AND ITS MANAGEMENT. International Journal of Research in Ayurveda and Pharmacy. https://doi.org/10.7897/2277-4343.04505
662. Saletu‐Zyhlarz, G., Anderer, P., & Saletu, B. (2013). [Sleep disorders in psychiatry and their treatment].. PubMed.
663. Salvà, A., Coll, L., & Luque, X. R. I. (2012). La fragilitat en les persones grans. Aloma: revista de psicologia, ciències de l'educació i de l'esport Blanquerna.
664. Samakouri, M., Arseniou, S., Keskeridou, F.-G., Gymnopoulou, M., & Livaditis, M. (2011). Poststroke depression in elderly, a review. European Psychiatry. https://doi.org/10.1016/s0924-9338(11)72531-7
665. Sampogna, G., Toni, C., Catapano, P., Rocca, B. D., Vincenzo, M. D., Luciano, M., & Fiorillo, A. (2023). New trends in personalized treatment of depression. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000903
666. Sandi, C. (2013). Stress and cognition. Wiley Interdisciplinary Reviews Cognitive Science. https://doi.org/10.1002/wcs.1222
667. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
668. Sappok, T., Schade, C., Kaiser, H. A., Došen, A., & Diefenbacher, A. (2011). Die Bedeutung des emotionalen Entwicklungsniveaus bei der psychiatrischen Behandlung von Menschen mit geistiger Behinderung. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0031-1273382
669. Sarkar, S. (2016). Psychiatric Polypharmacy, Etiology and Potential Consequences. Current Psychopharmacologye. https://doi.org/10.2174/2211556005666160916124719
670. Sarkar, S., Bhatia, G., & Dhawan, A. (2023). Clinical Practice Guidelines for Assessment and Management of Patients with Substance Intoxication Presenting to the Emergency Department. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_490_22
671. Sarris, J., O’Neil, A., Coulson, C., Schweitzer, I., & Berk, M. (2014). Lifestyle medicine for depression. BMC Psychiatry. https://doi.org/10.1186/1471-244x-14-107
672. Sarwer-Foner, G. J., & Ogle, W. (1956). Psychodynamic Aspects of Reserpine: Its Uses and Effects in Open Psychiatric Settings. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674375600100103
673. Savarimuthu, R. J. S., Kanniammal, C., Devi, N., & Savarimuttu, J. S. R. (2025). Nursing implication on perinatal depression. Ceylon Journal of Science. https://doi.org/10.4038/cjs.v54i2.8378
674. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
675. Schachter, S. C. (2006). Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.1.111
676. Schad, J. N. (2015). Mental Stress; Brain’s Complexity Resolution Dilemma. Journal of Neurology & Stroke. https://doi.org/10.15406/jnsk.2015.02.00058
677. Scheid, T. L., & Wright, E. R. (2017). Theoretical Perspectives on Mental Health and Illness: Introduction to Part I. Cambridge University Press eBooks. https://doi.org/10.1017/9781316471289.003
678. Scheidt, S., & Allan, R. N. (1996). Stress, Anger, and Psychosocial Factors for Coronary Heart Disease. https://doi.org/10.1093/oso/9780195085822.003.0011
679. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
680. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
681. Schildkrout, B. (2014). Disease #53: Postconcussion Syndrome. https://doi.org/10.1002/9781394260447.ch81
682. Schildkrout, B. (2014). Notable Physical Symptoms and Possible Associated Diseases. https://doi.org/10.1002/9781394260447.ch28
683. Schneeberger, S., Ricardo, A., Claussen, M. C., Heuss, S., Andres, S., & Malte, C. (2020). Sports Psychiatry. Women’s mental health in elite sports – we are missing the complexity. Swiss Sports & Exercise Medicine. https://doi.org/10.34045/sems/2020/42
684. Schneiderman, N., Ironson, G., & Siegel, S. D. (2004). Stress and Health: Psychological, Behavioral, and Biological Determinants. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.1.102803.144141
685. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
686. Schwab, M., & Rakers, F. (2022). Long-Term Effects of Prenatal Maternal Stress and Mental Health. Cambridge University Press eBooks. https://doi.org/10.1017/9781009272254.007
687. Schweitzer, B. (2006). Medically unexplained symptoms : main article. CME: Your SA Journal of CPD.
688. Scripcaru, C., Diac, M., Iacob, V. T., Scripcaru, A., & Chirilă, B. D. (2025). The social dangerousness and medico-legal risks of schizophrenia. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2025.1.05
689. Seikowski, K., Harth, W., & Hermes, B. (2008). Lifestyle Drugs in Old Age – A Mini-Review. Gerontology. https://doi.org/10.1159/000173697
690. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
691. Senay, E. C. (1989). Addictive Behaviors and Benzodiazepines:. Advances in Alcohol & Substance Abuse. https://doi.org/10.1300/j251v08n01_08
692. Serrano, J. L., Vila, S., Vidal, R. C., Padilla, E. B., Lamora, N. S., Mollà, L., Rodríguez, A. M., & López, L. M. M. (2017). COMORBILIDAD ENTRE DEPRESIÓN Y CONDUCTAS IMPULSIVAS: UN CASO DE URGENCIA NEGATIVA.
693. Serrano, R., Marinho, G., Almeida, D., & Cruz, M. D. C. (2021). As Alterações Do Humor Como Manifestações Precoces De Doenças Físicas – Uma Revisão. DOAJ (DOAJ: Directory of Open Access Journals).
694. Seth, S., Saurabh, S., Kataria, D., Prasad, S., & Kukreti, P. (2022). NEUROPSYCHIATRIC ASPECTS OF MOVEMENT DISORDERS. Indian Journal Of Applied Research. https://doi.org/10.36106/ijar/1901380
695. Setyaningrum, D. A. W. (2019). Cedera olahraga serta penyakit terkait olahraga. Jurnal Biomedika dan Kesehatan. https://doi.org/10.18051/jbiomedkes.2019.v2.39-44
696. SF, C., & Mb, S. (2018). Resilience and Chronic Disease: A Systematic Review. Journal of Addictive Behaviors Therapy & Rehabilitation. https://doi.org/10.4172/2324-9005.1000176
697. Sforza, M., Ferini‐Strambi, L., & Franceschini, C. (2024). Editorial: Psychological sleep studies: new insights to support and integrate clinical practice within the healthcare system, volume II. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2024.1525122
698. Shabbir, S. H. (2016). Psychiatric Underpinnings of Chronic Diabetic Neuropathic Pain. Einstein Journal of Biology and Medicine. https://doi.org/10.23861/ejbm201530639
699. Shankar, R., Wilcock, M., Oak, K., McGowan, P., & Sheehan, R. (2018). Stopping, rationalising or optimising antipsychotic drug treatment in people with intellectual disability and/or autism. Drug and Therapeutics Bulletin. https://doi.org/10.1136/dtb.2018.000009
700. Shapiro, P. A., Pereira, L. F., Levenson, J., & Worthington, C. (2024). Mood Disorders: Therapeutic Challenges in the Medically Ill Patient. Cambridge University Press eBooks. https://doi.org/10.1017/9781108973922.026
701. Sharabyani, S. M. (2016). MENTAL DISORDER AND THEIR TREATMENT. Journal of Fundamental and Applied Sciences. https://doi.org/10.4314/jfas.v8i3s.388
702. Sharma, V. (2021). Peripartum anxiety: parsing heterogeneity in clinical settings. Brazilian Journal of Psychiatry. https://doi.org/10.1590/1516-4446-2021-1952
703. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
704. Sharpe, M. (2020). Medically unexplained symptoms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0623
705. Sharpe, M., & Wilks, D. (2002). ABC of psychological medicine: Fatigue. BMJ. https://doi.org/10.1136/bmj.325.7362.480
706. Sheinfeld, H., Ga�l, M., Bunzel, M. E., & Vishne, T. (2007). The Etiology of Some Menstrual Disorders: A Gynecological and Psychiatric Issue. Health Care For Women International. https://doi.org/10.1080/07399330701563178
707. Shelton, R. C., & Hunt, A. J. (2008). Anxiety Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_9
708. Shenefelt, P. D. (2010). Update on psychodermatological disorders. Expert Review of Dermatology. https://doi.org/10.1586/edm.09.62
709. Sher, L. (2005). Type D personality: the heart, stress, and cortisol. QJM. https://doi.org/10.1093/qjmed/hci064
710. Sheykhi, M. T. (2020). Inevitable aging and the resultant mental disorders In developing countries: a sociological appraisal. Clinical Research and Clinical Trials. https://doi.org/10.31579/2693-4779/002
711. Shibasaki, H., & Hallett, M. (2016). Psychogenic Neurologic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190240974.003.0026
712. Shin, K. J., Lee, Y.-J., Yang, Y. R., Park, S., Suh, P., Follo, M. Y., Cocco, L., & Ryu, S. H. (2016). Molecular Mechanisms Underlying Psychological Stress and Cancer. Current Pharmaceutical Design. https://doi.org/10.2174/1381612822666160226144025
713. Silva, J. A. P. D., Geenen, R., & Jacobs, J. W. G. (2017). Chronic widespread pain and increased mortality: biopsychosocial interconnections. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2017-211893
714. Silva, T. D. O., Leite, J. R., Bezerra, W. D. S. P., Lima, M. B. L. D., & Fiorin, P. M. (2017). A DEPRESSÃO NA TERCEIRA IDADE:RELATO DE EXPERIÊNCIA DE UMA ATIVIDADE EDUCATIVA.
715. Silver, J., & Kay, T. W. H. (2013). Persistent Symptoms After a Concussion. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625154.da20
716. Silverman, M. N., & Deuster, P. A. (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus. https://doi.org/10.1098/rsfs.2014.0040
717. Singh, R., Sethi, K., & Rawat, P. (2021). Stress, Coping, Burnout and General Psychopathology among Medical Professionals. Webology. https://doi.org/10.29121/web/v18i4/6
718. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
719. Singh, S. K., Singh, R. K., & Singh, R. (2020). Health and psychological health in present time. Journal of Global Health Reports. https://doi.org/10.29392/001c.12225
720. Siwek, M., & Dudek, D. (2011). The impact of anxiety disorders on the quality of compliance among patients with co-morbid psychiatric or medical conditions: there are many questions but where can we find the answers?.
721. Slachevsky, A., & Fuentes, P. (2005). Síntomas psicológicos y conductuales asociados a demencias: actualización terapéutica. Revista médica de Chile. https://doi.org/10.4067/s0034-98872005001000015
722. Smith, J., & Selye, H. (1979). Reducing the Negative Effects of Stress. AJN American Journal of Nursing. https://doi.org/10.2307/3424527
723. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
724. Sobel, D. S. (1995). Rethinking Medicine. Psychosomatic Medicine. https://doi.org/10.1097/00006842-199505000-00005
725. Sobrido, M. J., Silva, J. J. D., & Castro, B. Q. (2009). Trastornos del comportamiento en la enfermedad de Parkinson. Aspectos genéticos, farmacológicos y médico-legales. Revista de Neurología. https://doi.org/10.33588/rn.48s01.2008730
726. Sobrido, M., Dias-Silva, J. J., & Quintáns, B. (2009). [Behavioral disorders in Parkinson's disease. Genetic, pharmacological and medico-legal aspects]..
727. Soe, K. C., & Lopez, W. L. (2022). Clinical progress note: Management of somatic symptom and related disorders in pediatric inpatients. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.12947
728. Soler, C. L. (2008). Las reacciones postraumáticas en la infancia y adolescencia maltratada: el trauma complejo. Revista de Psicopatología y Psicología Clínica. https://doi.org/10.5944/rppc.vol.13.num.3.2008.4057
729. Solmi, M., Bortolato, B., Veronese, N., Stubbs, B., Herrmann, N., & Carvalho, A. F. (2019). Pharmacological Interventions for Cognitive Dysfunction in Major Depressive Disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198810940.003.0018
730. Sonino, N., & Fava, G. A. (2007). Rehabilitation in Endocrine Patients: A Novel Psychosomatic Approach. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000107558
731. Soyuer, F., & Kepenek-Varol, B. (2019). Quality of life and pain. International Journal of Family & Community Medicine. https://doi.org/10.15406/ijfcm.2019.03.00140
732. Sołtys, K., Bidzan, L., Turczyński, J., & Łapin, J. (2005). [Assessment of early traumatic life events influence on intensity and frequency of symptoms in patients aged 50 years and over].. PubMed.
733. Spector, P. E. (2002). Employee Control and Occupational Stress. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00185
734. Sporty, L., & Plon, L. (1984). Rapid, Psychopharmacologically Induced Improvement Can Produce New Psychological Symptoms. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674378402900314
735. Srivastav, D., & Singh, T. B. (2016). Comorbidity Issues and Treatment in Chronic Mental Illness. Advances in psychology, mental health, and behavioral studies (APMHBS) book series. https://doi.org/10.4018/978-1-5225-0519-8.ch005
736. Stacher, G. (1993). Psyche, personality and gut functions. Neurogastroenterology & Motility. https://doi.org/10.1111/j.1365-2982.1993.tb00110.x
737. Stack, R. (2018). SP0030 Reasons for delay in help seeking at the onset of symptoms. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2018-eular.7839
738. Stahl, S. M. (2002). Can Psychopharmacologic Treatments That Relieve Symptoms Also Prevent Disease Progression?. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n1101
739. Stahl, S. M., & Morrissette, D. A. (2018). Treatment of Secondary Behavioral Symptoms of Dementia. https://doi.org/10.1017/9781107706842.008
740. Stanca, A., Carella, M. C., Basile, P., Forleo, C., Ciccone, M. M., & Guaricci, A. I. (2024). Cardiomyopathies and Psychiatric Disorders: An Overview and General Clinical Recommendations. Cardiology in Review. https://doi.org/10.1097/crd.0000000000000693
741. Starkstein, S., & Robinson, R. G. (1989). Affective Disorders and Cerebral Vascular Disease. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.154.2.170
742. Stefano, G. B., Esch, T., Fricchione, G. L., & Benson, H. (2002). Stress in cardiovascular diseases.. PubMed.
743. Stefano, G. B., Esch, T., Fricchione, G. L., & Benson, H. (2002). The role of stress in neurodegenerative diseases and mental disorders.. PubMed.
744. Steffens, D. C., & Potter, G. G. (2007). Geriatric depression and cognitive impairment. Psychological Medicine. https://doi.org/10.1017/s003329170700102x
745. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
746. Stegner, A. J., Shields, M. R., Meyer, J. D., & Cook, D. B. (2013). Physical Activity, Stress Reactivity, and Stress-Mediated Pathophysiology. Routledge eBooks. https://doi.org/10.4324/9780203132678-34
747. Steinert, T., Heinz, A., Hohl-Radke, F., Köller, M., Müller, J., Müller, S., & Zinkler, M. (2016). [What is a "Considerable Damage to One's Health" in the Sense of German Guardianship Law?]. Psychiatrische Praxis.
748. Steptoe, A. (2017). Depression and negative emotions. Routledge eBooks. https://doi.org/10.4324/9781315673097-6
749. Stojaković, M., & Stojakovic, B. (2017). FORENZIČKO PSIHIJATRIJSKI ASPEKTI VJEŠTAČENJA BOLESTI ZAVISNOSTI. Psymedica. https://doi.org/10.7251/psy1302047s
750. Stojaković, M., Vukadinović, S., & Stojanović, Z. (2017). STRES KAO FAKTOR RIZIKA U NASTANKU DEPRESIJE NAKON MOŽDANOG UDARA. Psymedica. https://doi.org/10.7251/psy1201016v
751. Stoller, K. B. (2015). Psychiatric Co-occurring Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214647.003.0015
752. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
753. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
754. Strain, J. J., Klipstein, K., & Newcorn, J. H. (2008). Adjustment Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch81
755. Stratakis, C. A., Gold, P. W., & Chrousos, G. P. (1995). Neuroendocrinology of Stress: Implications for Growth and Development. Hormone Research. https://doi.org/10.1159/000184269
756. Stępień, A., & Małyszczak, K. (2008). Psychic consequences of natural disasters.
757. Sudheimer, K., Flournoy, J. C., Gershon, A., Demuth, B., Schatzberg, A. F., & O’Hara, R. (2013). The Hpa Axis and Late-Life Depression. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199796816.003.0040
758. Sugden, S. G., Merlo, G., & Bachtel, G. (2023). Bipolar Disorders. CRC Press eBooks. https://doi.org/10.1201/b22810-32
759. SUMINAR, T. E. L., & Diniari, N. K. S. (2023). GANGGUAN CEMAS PADA LANSIA : SEBUAH LAPORAN KASUS. HEALTHY Jurnal Inovasi Riset Ilmu Kesehatan. https://doi.org/10.51878/healthy.v2i2.2574
760. Sumiyoshi, T., Matsuoka, T., & Kurachi, M. (2012). Role for Pituitary Neuropeptides in Social Behavior Disturbances of Schizophrenia. InTech eBooks. https://doi.org/10.5772/52326
761. Sushmitha, S., Shivakumara, J., & Mathias, T. (2023). Stress, a Great Impact on Mental Health. Asian Journal of Nursing Education and Research. https://doi.org/10.52711/2349-2996.2023.00050
762. Sutor, B., Rummans, T. A., & Lapid, M. I. (2006). Atypical neuropsychiatric symptoms in the elderly.
763. Svenaeus, F. (2013). Psychopharmacology and the Self. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199579563.013.0068
764. Swann, A. C. (2009). Pharmacologic Mood Destabilization: <i>Case Vignettes</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900003898
765. Swann, A. C. (2014). Non-pharmacological and pharmacological treatments act on the same brain. World Psychiatry. https://doi.org/10.1002/wps.20166
766. Syamsir, B. S. (2010). Gangguan Depresif pada Orang Usia Lanjut.
767. Szerman, N., Ferre, F., Basurte-Villamor, I., Vega, P., Mesías, B., Marín-Navarrete, R., & Arango, C. (2020). Gambling Dual Disorder: A Dual Disorder and Clinical Neuroscience Perspective. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2020.589155
768. Szmulewicz, A., Smith, J., & Valerio, M. P. (2015). [ATTENUATED PSYCHOSIS SYNDROME: A LITERATURE REVIEW].. PubMed.
769. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
770. Szymkowicz, S. M., Gerlach, A., Homiack, D., & Taylor, W. D. (2023). Biological factors influencing depression in later life: role of aging processes and treatment implications. Translational Psychiatry. https://doi.org/10.1038/s41398-023-02464-9
771. Sánchez, L. C., Cardona, A., cordoba, S., Silva, A. V., Ruiz, A. C., Ibáñez‐Pinilla, M., Pérez-Olmos, I., & Flórez, J. (2010). Experiencias de estigma en personas con enfermedad mental y su impacto en la autoestima en Colombia. reponame:Repositorio Institucional EdocUR.
772. Tacn, A. (2012). PTSD in the Context of Malignant Disease. InTech eBooks. https://doi.org/10.5772/27424
773. Tan, J. C. H. (2013). Mental Health. The Encyclopedia of Cross‐Cultural Psychology. https://doi.org/10.1002/9781118339893.wbeccp357
774. Tancredi, O. (1983). [Adaptation to chronic illness].. PubMed.
775. Tang, C.-P. (2016). The Forgotten Child.. PubMed.
776. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
777. Taschereau‐Dumouchel, V., Michel, M., Lau, H., Hofmann, S. G., & LeDoux, J. E. (2022). Putting the “mental” back in “mental disorders”: a perspective from research on fear and anxiety. Molecular Psychiatry. https://doi.org/10.1038/s41380-021-01395-5
778. Taylor, R., Smith, B. H., & Teijlingen, E. V. (2003). Chronic illness. https://doi.org/10.1093/oso/9780192631688.003.0015
779. Teixeira, A. L., Martins, L. B., Berk, M., & Bauer, M. E. (2022). Severe psychiatric disorders and general medical comorbidities: inflammation-related mechanisms and therapeutic opportunities. Clinical Science. https://doi.org/10.1042/cs20211106
780. Telles‐Correia, D., Barbosa, A., & Mega, I. (2009). Psychiatric Assessment of Anxiety and Depression in Medical Patient. European Psychiatry. https://doi.org/10.1016/s0924-9338(09)70969-1
781. Terman, M., & Terman, J. S. (2013). Chronotherapeutics. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.026
782. Terrazas, E. E., López, A. G., Hernando, M., & Barquero, M. J. G. (2011). "Depresión": Imprecisión diagnóstica y terapéutica. Importantes consecuencias en la práctica clínica. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352011000300005
783. Thom, R. P., Silbersweig, D., & Boland, R. (2019). Major Depressive Disorder in Medical Illness: A Review of Assessment, Prevalence, and Treatment Options. Psychosomatic Medicine. https://doi.org/10.1097/psy.0000000000000678
784. Thomas, P. (2003). Treatment options for acute mania. European Psychiatry. https://doi.org/10.1016/s0924-9338(03)80011-1
785. Thompson, D. R., & Ski, C. F. (2013). Psychosocial interventions in cardiovascular disease – what are they?. European Journal of Preventive Cardiology. https://doi.org/10.1177/2047487313494031
786. Thompson, T. R., & McDonald, W. M. (2002). The Assessment of Depressive States. https://doi.org/10.1002/0470846410.ch29
787. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
788. Tible, O., Riese, F., Savaskan, E., & Gunten, A. V. (2017). Best practice in the management of behavioural and psychological symptoms of dementia. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756285617712979
789. Timour, Q., Frassati, D., Descotes, J., Chevalier, P., Christé, G., & Chahine, M. (2012). Sudden Death of Cardiac Origin and Psychotropic Drugs. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2012.00076
790. Todorović, S. (2016). Socijalno medicinske karakteristike i razlike između alkoholičara sa periodičnim i kontinuiranim pijenjem / Social and Medical Characteristics and Differences Between Alcoholics With Periodic and Continuous Drinking. SESTRINSKI ŽURNAL. https://doi.org/10.7251/sez0116005t
791. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
792. Torales, J., Malatesta, E. M., González, L. L., González, I., López, R. D. A., Barrios, J. I., García, O. E., O’Higgins, M., Castaldelli-Maia, J. M., & Ventriglio, A. (2020). Psychodermatology: An introduction to its concepts, nosology and approach models. Anales de la Facultad de Ciencias Médicas (Asunción). https://doi.org/10.18004/anales/2020.053.02.127
793. Torregrossa, W., Raciti, L., Rifici, C., Rizzo, G., Raciti, G., Casella, C., Naro, A., & Calabrò, R. S. (2023). Behavioral and Psychiatric Symptoms in Patients with Severe Traumatic Brain Injury: A Comprehensive Overview. Biomedicines. https://doi.org/10.3390/biomedicines11051449
794. Townsend, M. C. (2004). Nursing diagnoses in psychiatric nursing : care plans and psychotropic medications. F.A. Davis Co. eBooks.
795. Treisman, G. J., & Clark, M. R. (2011). A Behaviorist Perspective. Advances in psychosomatic medicine. https://doi.org/10.1159/000324063
796. Trill, M. D. (2012). Psychological aspects of depression in cancer patients: an update. Annals of Oncology. https://doi.org/10.1093/annonc/mds350
797. Truyol, C. D. C. G., & Psicología, M. E. (2017). Factores de vulnerabilidad asociados a la génesis del trastorno depresivo persistente (distimia) con ansiedad en un paciente adulto mayor.
798. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
799. Turk, D. C. (1996). Psychological Aspects of Chronic Pain and Disability. Journal of Musculoskeletal Pain. https://doi.org/10.1300/j094v04n04_14
800. Turk, J., Graham, P. L., & Verhulst, F. C. (2007). Prevention and treatment. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199216697.003.0009
801. Turk, J., Graham, P., & Verhulst, F. C. (2007). Introduction. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199216697.003.0001
802. Tuszyńska-Bogucka, W., & Nawra, K. (2014). Paternal Postnatal Depression - a review. Archives of Psychiatry and Psychotherapy. https://doi.org/10.12740/app/26286
803. Túry, F., & Kovács-Tóth, B. (2019). [The role of traumatization in eating disorders. Possible therapeutic modalities with special regard to cognitive behavioural methods].. PubMed.
804. Tütüncü, R. (2011). •Chronic pain, psychological factors and depression. Dicle Medical Journal / Dicle Tip Dergisi. https://doi.org/10.5798/diclemedj.0921.2011.02.0028
805. Ubaidi, B. A. A. (2017). Integrate of Spiritual Needs into Patient Care. Journal of Family Medicine and Disease Prevention. https://doi.org/10.23937/2469-5793/1510056
806. Undiyaundeye, F. A., & Agbama, I. A. (2022). Post-Traumatic Stress Disorder among Military Personnel in Nigeria: A Social Approach. Scholars Journal of Agriculture and Veterinary Sciences. https://doi.org/10.36347/sjahss.2022.v10i09.001
807. Urban‐Kowalczyk, M. (2016). Psychiatric Complications of Celiac Disease. International Journal of Celiac Disease. https://doi.org/10.12691/ijcd-3-1-1
808. Valle, A. (2019). PHYSICAL ACTIVITY EFFECTS IN OLDER PEOPLE AT RISK WITH FRAGILITY SYNDROME.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8619
809. Vargas, X. R., Leal, M. L. A., & Zamora, S. M. (2020). Actualización del trastorno afectivo bipolar. Revista Medica Sinergia. https://doi.org/10.31434/rms.v5i9.572
810. Vasileva, A. V. (2017). The Impact of Mental Factor as an Indicator of the Population State of Health. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.281
811. Vasiliu, O., & Vasile, D. (2016). Risk factors and quality of life in late-life depressive disorders. Romanian Journal of Military Medicine. https://doi.org/10.55453/rjmm.2016.119.3.5
812. Vasudev, S. R. (2016). New Innovations in Disease Diagnosis: A Review.
813. Ventriglio, A., Gentile, A. J., Baldessarini, R. J., & Bellomo, A. (2015). Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets. Current Pharmaceutical Design. https://doi.org/10.2174/1381612821666150105121244
814. Veras, A. B., do-Nascimento, J. S., Rodrigues, R. L., Guimarães, A. C. A., & Nardi, A. E. (2011). Psychotic symptoms in social anxiety disorder patients: report of three cases. International Archives of Medicine. https://doi.org/10.1186/1755-7682-4-12
815. Verdolini, N., & Vieta, E. (2021). Resilience, prevention and positive psychiatry. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13288
816. Verma, S., & Agrawal, R. (2021). The lasting effects of childhood trauma. Current psychiatry. https://doi.org/10.12788/cp.0101
817. Vicente, M. O., Gutiérrez, L. E. J. F., & Oves, M. I. R. (2011). ALCOHOLISMO CONSECUTIVO AL TRASTORNO DE PÁNICO. DOAJ (DOAJ: Directory of Open Access Journals).
818. Vigueras, P., Vigueras, J. P., Meca, R. L., Fernández, P. R., Retuerto, B. M., González, J. G., & Gaspar, J. C. (2011). La crisis económica y las urgencias hospitalarias generales y psiquiátricas. Puesta al día en urgencias, emergencias y catástrofes.
819. Vizcaíno-Cárdenas, G. S., Conde, L. G. R., & Vizcaíno-Cárdenas, T. A. (2022). Factores Asociados a la Carga Mental en Docentes de Instituciones Educativas Ecuatorianas. Mediciencias UTA (Impresa)/Mediciencias UTA (En línea). https://doi.org/10.31243/mdc.uta.v6i2.1631.2022
820. Vollam, S., & Efstathiou, N. (2022). Special issue: Rehabilitation in and after critical care. Nursing in Critical Care. https://doi.org/10.1111/nicc.12755
821. Voon, V., Thomsen, T., Miyasaki, J. M., Souza, M. D., Shafro, A., Fox, S. H., Duff‐Canning, S., Lang, A. E., & Zurowski, M. (2007). Factors Associated With Dopaminergic Drug–Related Pathological Gambling in Parkinson Disease. Archives of Neurology. https://doi.org/10.1001/archneur.64.2.212
822. Vrhovski, D. (2016). Sindrom pretreniranosti u trkača.
823. Vuppalapati, C., Kedari, S., Ilapakurti, A., Kedari, S., & Shankar, J. (2019). Emotional Health: A Data Driven Approach to Understand our Emotions and Improve our Health. https://doi.org/10.1109/cse/euc.2019.00071
824. Vy, S. (2007). Psychosomatic aspects of ethnopsychology and ethnopsychotherapy.. PubMed.
825. Víu, C. M. D., & Blasco, J. M. (2011). Salud laboral y salud mental: estado de la cuestión. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2011000500001
826. Wafa, M. H. (2019). Identification des facteurs biopsychosociaux prédictif du trouble de stress post-traumatique chez les patients admis dans le service d’urgence après un traumatisme.
827. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
828. Walder, D. J., Statucka, M., Daly, M., & Yaffe, B. (2014). Psychotic Disorders. Psychology. https://doi.org/10.1093/obo/9780199828340-0151
829. Wallner, R., Senczyszyn, A., Budrewićz, S., & Rymaszewska, J. (2019). Zaburzenia poznawcze i neuropsychiatryczne w chorobie Parkinsona. Polski Przegląd Neurologiczny. https://doi.org/10.5603/ppn.2019.0018
830. Wang, S. (2013). Research development of posttraumatic growth and metal health. Chinese Journal of Injury Repair and Wound Healing.
831. Weaver, M. (2018). Substance-Related Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615371990.jl16
832. Weber, P., Vepřeková, B., & Kadaňka, Z. (2009). Psychiatrická problematika v intenzivní medicíně vyššího věku.
833. Weems, C. F. (2019). The importance of the post-disaster context in fostering human resilience. The Lancet Planetary Health. https://doi.org/10.1016/s2542-5196(19)30014-2
834. Weibert, E., & Stengel, A. (2019). Die Rolle Der Psychotherapie Beim Reizdarmsyndrom. PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie. https://doi.org/10.1055/a-0829-6990
835. Weigel, G. (2014). Critical Additions Required. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488b
836. Wenzel, T., & Zhu, L. (2013). Posttraumatic Stress in Athletes. https://doi.org/10.1002/9781118404904.ch10
837. White, C. A., & Trief, P. M. (2005). Psychotherapy For Medical Patients. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198520641.003.0033
838. Wilkins, M. K., & Moore, M. L. (2004). Music intervention in the intensive care unit: a complementary therapy to improve patient outcomes. Evidence-Based Nursing. https://doi.org/10.1136/ebn.7.4.103
839. Williams, C. Y. K., Knight, R., Donnelly, N., & Bance, M. (2020). Prevalence and treatment of co‐morbid anxiety and depression among 352 dizzy patients: A retrospective study. Clinical Otolaryngology. https://doi.org/10.1111/coa.13590
840. Willroth, E. C., James, B. D., Graham, E. K., Kapasi, A., Bennett, D. A., & Mroczek, D. K. (2022). Well-being and Cognitive Resilience to Dementia-related Neuropathology. https://doi.org/10.31234/osf.io/sbh85
841. Wilson, C. B. (2014). The Roles of Inflammation, Oxidative Stress, and Neurotransmitters in an Animal Model of Post-Traumatic Stress Disorder. https://doi.org/10.31390/gradschool_dissertations.1323
842. Wilson, M. P., & Vilke, G. M. (2013). The patient with excited delirium in the emergency department. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139088077.021
843. Winkelmann, C., & Schreiber, T. (2019). Using ’White Flags’ to categorize socio-cultural aspects in chronic pain. European Journal of Public Health. https://doi.org/10.1093/eurpub/ckz186.196
844. Wise, M. G., & Griffies, W. S. (1995). A combined treatment approach to anxiety in the medically ill.. PubMed.
845. Wolever, R. Q. (2007). Managing Stress to Manage Heart Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-452-0_6
846. Wolkowitz, O. M. (2018). Accelerated biological aging in serious mental disorders. World Psychiatry. https://doi.org/10.1002/wps.20546
847. Wong, A. Y. L., Karppinen, J., & Samartzis, D. (2017). Low back pain in older adults: risk factors, management options and future directions. Scoliosis and Spinal Disorders. https://doi.org/10.1186/s13013-017-0121-3
848. Woo, S., & Keatinge, C. (2016). Neurodevelopmental Disorders I: Autism Spectrum Disorder. https://doi.org/10.1002/9781394259472.ch4
849. Wood, G. W. (2006). Intramedullary nailing of femoral and tibial shaft fractures. Journal of Orthopaedic Science. https://doi.org/10.1007/s00776-006-1061-6
850. Worthen, R. J., & Beurel, E. (2022). Inflammatory and neurodegenerative pathophysiology implicated in postpartum depression. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2022.105646
851. Wortzel, H. S., Brenner, L. A., & Silver, J. (2018). Traumatic Brain Injury. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy12
852. Wreksoatmodjo, B. R. (2014). Beberapa Kondisi Fisik dan Penyakit yang MerupakanFaktor Risiko Gangguan Fungsi Kognitif (Some Physical Conditions and Diseases as Risk Factors for Cognitive Decline).
853. Wrosch, C., Schulz, R., & Heckhausen, J. (2004). Health Stresses and Depressive Symptomatology in the Elderly. Current Directions in Psychological Science. https://doi.org/10.1111/j.0963-7214.2004.01301005.x
854. Wulff, C., Lindfors, P., & Sverke, M. (2010). Are general mental ability and psychosocial work characteristics related to midlife health in working women and men. USC Research Bank (University of the Sunshine Coast).
855. Wulff, C., Lindfors, P., & Sverke, M. (2011). Do general mental ability and psychosocial work characteristics predict different aspects of health in middle-aged working women and men?.
856. Xiao, J., Chan, C. W., & Chow, K. M. (2019). LIVING WITH DIGNITY AMONG CHINESE CANCER PATIENTS UNDERGOING CHEMOTHERAPY: A QUALITATIVE STUDY. https://doi.org/10.26226/morressier.5cdbe0ab618793e647b12cfb
857. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
858. Yoshihara, K. (2015). Psychosomatic treatment for allergic diseases. BioPsychoSocial Medicine. https://doi.org/10.1186/s13030-015-0036-2
859. Young, C., & Horton, J. (2019). Canine and Equine Therapy for Mental Health: A Review of Clinical Effectiveness [Internet].
860. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
861. Zhu, S., Luo, X., Li, Y.-F., Kurihara, H., & He, R. (2018). [Emotional stress-induced Shanghuo syndrome increases disease susceptibility].. PubMed. https://doi.org/10.19540/j.cnki.cjcmm.20180104.021
862. Zikmund, V. (1997). [Psychological and psychosocial factors in sudden cardiac death].. PubMed.
863. Zięba, A. A., Dudek, D., Jawor, M., & Krzysiek, J. (1999). [Sexual dysfunctions in depressed patients].. PubMed.
864. Zoellner, L. A., Graham, B., & Bedard‐Gilligan, M. (2019). Trauma- and Stressor-Related Disorders. Routledge eBooks. https://doi.org/10.4324/9780429028267-10
865. Zorumski, C. F., & Rubin, E. H. (2009). What Illnesses Do Psychiatrists Treat?. https://doi.org/10.1093/oso/9780195386400.003.0002
866. Zúñiga, R. L. (2017). Delirium y la presencia de respuesta inflamatoria sistémica, descontrol glucémico e hipoxia en pacientes mayores de 65 años en el servicio de urgencias médicas del Hospital General de Pachuca..
867. Ángeles, S. T. (2013). Perfil de estrés académico en alumnos de licenciatura en psicología, de la Universidad Autónoma de Hidalgo en la escuela superior de Actopan.
868. Ávalos, A. J. P., Rodríguez, T. R., & Alfonso, J. A. P. (2018). Factores de riesgo emocionales en pacientes que sufren dolor crónico de espalda. DOAJ (DOAJ: Directory of Open Access Journals).
869. Ćurčić, V. (2011). Psiholoski odnos prema telu i gojaznost adolescenata. Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor. https://doi.org/10.5937/medgla1139094c
870. Češková, E. (2013). Practical issues in the treatment of schizophrenia. Minerva psichiatrica e psicologica.
871. Šabić, A. (2018). Stres i psorijaza.
872. Šibor, J., Holý, L., & Rezáková, O. (2005). RÁMCOVÝ (ŠKOLNÍ) VZDĚLÁVACÍ PROGRAM VE VZTAHU K DUŠEVNÍM ABEHAVIORÁLNÍM PORUCHÁMSTRES.